,Unnamed: 0,x,y,v,Subtypes,colors,ENST00000429829.6|ENSG00000229807.13|OTTHUMG00000021839.13|OTTHUMT00000057239.2|XIST-204|XIST|19245|,ENST00000597346.1|ENSG00000269821.1|OTTHUMG00000171022.2|OTTHUMT00000411275.2|KCNQ1OT1-201|KCNQ1OT1|91667|,ENSMUST00000127786.4|ENSMUSG00000086503.5|OTTMUSG00000018295.5|OTTMUST00000044201.4|Xist-201|Xist|17946|lncRNA|,ENSMUST00000185789.3|ENSMUSG00000101609.3|OTTMUSG00000046380.3|OTTMUST00000120849.3|Kcnq1ot1-201|Kcnq1ot1|93092|lncRNA|
0,0,0,0,TraAT: Transition between A and T,Transcript related,#CCB441,0.144253,0.097673,0.14538900000000002,0.115041
1,1,0,1,SLFBC: Sum of path lengths starting from oxygens_3 transition between B and C,Topological indice,#B4B044,0.14426,0.097676,0.145397,0.115045
2,2,0,2,LFI: Lipoaffinity index_3110,Solubility lipoaffinity,#D1963A,33.775005,27.0009,33.210743,27.767591
3,3,0,3,PCDAA: Parallel correlation PseDN composition of AA,Nucleotide related,#ED7D31,0.071,0.062,0.066,0.065
4,4,0,4,SHA: Strong H-Bond acceptors_3011,Hydrogen bond related,#FFC000,38.971161,30.967699,37.501392,34.567818
5,5,0,5,SCDAA: Series correlation PseDN composition of AA,Nucleotide related,#ED7D31,0.077,0.069,0.07400000000000001,0.073
6,6,0,6,SHA: Strong H-Bond acceptors_3110,Hydrogen bond related,#FFC000,43.543777,34.301144,40.120361,36.401215
7,7,0,7,TraEK: Entropy density K on transcript,Transcript related,#CCB441,0.053103,0.049413,0.047569,0.051589
8,8,0,8,SLF: Sum of path lengths starting from oxygens_3110,Topological indice,#B4B044,31.280851,31.434381,31.093281,34.834496
9,9,0,9,LFICB: Lipoaffinity index_3 composition of B,Solubility lipoaffinity,#D1963A,0.268239,0.25808400000000004,0.265199,0.268718
10,10,0,10,ComRA: Composition of A,Transcript related,#CCB441,0.268174,0.258075,0.265129,0.268676
11,11,0,11,ORFEK: Entropy density K on ORF,Open reading frame,#BDC6CF,0.0551,0.048723,0.0,0.010104
12,12,0,12,SHACB: Strong H-Bond acceptors_3 composition of B,Hydrogen bond related,#FFC000,0.268239,0.25808400000000004,0.265199,0.268718
13,13,0,13,TPSB0: Topological polar surface area_3 distribution of 0.00B,Topological indice,#B4B044,0.000156,0.000267,0.000223,0.0004
14,14,0,14,HPCC0: Gas-hexadecane PC_3 distriCution of 0.00C,Partition coefficient,#C6CEBA,0.000156,0.000267,0.000223,0.0004
15,15,0,15,PSNB0: Primary or secondary nitrogens distribution of 0.00B,Topological indice,#B4B044,0.000156,0.000267,0.000223,0.0004
16,16,0,16,SLFC0: Sum of path lengths starting from oxygens_3 distriCution of 0.00C,Topological indice,#B4B044,0.000156,0.000267,0.000223,0.0004
17,17,0,17,DPRT0: Distribution of 0.00T,Transcript related,#CCB441,0.000156,0.000267,0.000223,0.0004
18,18,0,18,MLFA0: Linear free energy distribution of 0.00A,Hydrogen bond related,#FFC000,0.000156,3.3e-05,0.000167,3.3e-05
19,19,0,19,SHAA0: Strong H-Bond acceptors_3 distribution of 0.00A,Hydrogen bond related,#FFC000,5.2e-05,6.7e-05,5.600000000000001e-05,6.7e-05
20,20,0,20,CNHB0: NH- count distribution of 0.00B,Molecular fingerprint,#9AB6D1,5.2e-05,6.7e-05,5.600000000000001e-05,6.7e-05
21,21,0,21,MLFB0: Linear free energy distribution of 0.00B,Hydrogen bond related,#FFC000,5.2e-05,6.7e-05,5.600000000000001e-05,6.7e-05
22,22,0,22,LFIA0: Lipoaffinity index distribution of 0.00A,Solubility lipoaffinity,#D1963A,5.2e-05,6.7e-05,5.600000000000001e-05,6.7e-05
23,23,0,23,SLFA0: Sum of path lengths starting from oxygens_3 distribution of 0.00A,Topological indice,#B4B044,5.2e-05,6.7e-05,5.600000000000001e-05,6.7e-05
24,24,0,24,SHDB0: Strong H-Bond donors distribution of 0.00B,Hydrogen bond related,#FFC000,5.2e-05,6.7e-05,5.600000000000001e-05,6.7e-05
25,25,0,25,TPSC0: Topological polar surface area_3 distriCution of 0.00C,Topological indice,#B4B044,5.2e-05,6.7e-05,5.600000000000001e-05,6.7e-05
26,26,0,26,PHBC0: Potential Hydrogen Bonds_3 distriCution of 0.00C,Hydrogen bond related,#FFC000,5.2e-05,6.7e-05,5.600000000000001e-05,6.7e-05
27,27,0,27,DPRG0: Distribution of 0.00G,Transcript related,#CCB441,5.2e-05,6.7e-05,5.600000000000001e-05,6.7e-05
28,28,1,0,PHB: Potential Hydrogen Bonds_3000,Hydrogen bond related,#FFC000,204.104965,122.604088,191.296112,142.47142
29,29,1,1,PHB: Potential Hydrogen Bonds_300,Hydrogen bond related,#FFC000,337.594177,233.274445,328.541168,267.975586
30,30,1,2,TraEI: Entropy density I on transcript,Transcript related,#CCB441,0.059564,0.043606,0.057439,0.048441000000000005
31,31,1,3,LFI: Lipoaffinity index_3011,Solubility lipoaffinity,#D1963A,37.360352,27.634254,35.27248400000001,29.967665000000004
32,32,1,4,TraEN: Entropy density N on transcript,Transcript related,#CCB441,0.040914,0.036533,0.040341,0.038379
33,33,1,5,LFI: Lipoaffinity index011,Solubility lipoaffinity,#D1963A,54.35178000000001,46.368214,52.212193,49.501652
34,34,1,6,LFI: Lipoaffinity index110,Solubility lipoaffinity,#D1963A,54.29982,46.368214,52.212193,49.501652
35,35,1,7,SLF: Sum of path lengths starting from oxygens_3011,Topological indice,#B4B044,32.372044,34.134471999999995,31.650507,34.467815
36,36,1,8,SHA: Strong H-Bond acceptors_3101,Hydrogen bond related,#FFC000,36.840736,33.467781,37.334225,39.83466
37,37,1,9,SLFCB: Sum of path lengths starting from oxygens_3 composition of B,Topological indice,#B4B044,0.268239,0.25808400000000004,0.265199,0.268718
38,38,1,10,ORFEN: Entropy density N on ORF,Open reading frame,#BDC6CF,0.037425,0.02976,0.0317,0.0
39,39,1,11,LFICB: Lipoaffinity index composition of B,Solubility lipoaffinity,#D1963A,0.268239,0.25808400000000004,0.265199,0.268718
40,40,1,12,SLF: Sum of path lengths starting from oxygens_3101,Topological indice,#B4B044,34.762276,40.701355,32.597794,44.468147
41,41,1,13,SHA: Strong H-Bond acceptors_3200,Hydrogen bond related,#FFC000,50.974277,51.501717,55.778446,49.568317
42,42,1,14,SHA: Strong H-Bond acceptors_320,Hydrogen bond related,#FFC000,85.788513,88.83629599999998,91.886772,87.90293100000002
43,43,1,15,ORFEP: Entropy density P on ORF,Open reading frame,#BDC6CF,0.084453,0.079474,0.052546,0.053295
44,44,1,16,TraEP: Entropy density P on transcript,Transcript related,#CCB441,0.063847,0.069104,0.059971,0.061025
45,45,1,17,PHB: Potential Hydrogen Bonds_3011,Hydrogen bond related,#FFC000,30.709274,32.001068,26.468294,29.834328000000006
46,46,1,18,LFIB0: Lipoaffinity index_3 distribution of 0.00B,Solubility lipoaffinity,#D1963A,0.000312,3.3e-05,0.000167,3.3e-05
47,47,1,19,LFIB0: Lipoaffinity index distribution of 0.00B,Solubility lipoaffinity,#D1963A,0.000312,3.3e-05,0.000167,3.3e-05
48,48,1,20,PHBA0: Potential Hydrogen Bonds_3 distribution of 0.00A,Hydrogen bond related,#FFC000,0.000156,3.3e-05,0.000167,3.3e-05
49,49,1,21,SHAB0: Strong H-Bond acceptors_3 distribution of 0.00B,Hydrogen bond related,#FFC000,0.000312,3.3e-05,0.000167,3.3e-05
50,50,1,22,TPSA0: Topological polar surface area_3 distribution of 0.00A,Topological indice,#B4B044,0.000104,3.3e-05,0.000167,3.3e-05
51,51,1,23,CNHA0: NH- count distribution of 0.00A,Molecular fingerprint,#9AB6D1,0.000104,3.3e-05,0.000167,3.3e-05
52,52,1,24,HPCB0: Gas-hexadecane PC distribution of 0.00B,Partition coefficient,#C6CEBA,0.000104,0.000167,0.000279,0.0003
53,53,1,25,SHAC0: Strong H-Bond acceptors_3 distriCution of 0.00C,Hydrogen bond related,#FFC000,0.000104,0.000167,0.000279,0.0003
54,54,1,26,PSNA0: Primary or secondary nitrogens distribution of 0.00A,Topological indice,#B4B044,5.2e-05,3.3e-05,5.600000000000001e-05,3.3e-05
55,55,1,27,LFIC0: Lipoaffinity index_3 distriCution of 0.00C,Solubility lipoaffinity,#D1963A,5.2e-05,6.7e-05,5.600000000000001e-05,6.7e-05
56,56,2,0,MLF: Linear free energy000,Hydrogen bond related,#FFC000,204.104965,122.604088,191.296112,142.47142
57,57,2,1,MLF: Linear free energy00,Hydrogen bond related,#FFC000,337.594177,233.274445,328.541168,267.975586
58,58,2,2,PCDAG: Parallel correlation PseDN composition of AG,Nucleotide related,#ED7D31,0.066,0.046,0.066,0.051
59,59,2,3,SCDAG: Series correlation PseDN composition of AG,Nucleotide related,#ED7D31,0.07200000000000001,0.051,0.073,0.057
60,60,2,4,LFI: Lipoaffinity index_3101,Solubility lipoaffinity,#D1963A,35.126007,29.900997,36.052601,33.367779
61,61,2,5,HPC: Gas-hexadecane PC_3002,Partition coefficient,#C6CEBA,64.068588,58.03526700000001,59.456146,60.50201800000001
62,62,2,6,PHB: Potential Hydrogen Bonds_3002,Hydrogen bond related,#FFC000,75.656013,64.068802,73.721161,71.869064
63,63,2,7,PHB: Potential Hydrogen Bonds_3200,Hydrogen bond related,#FFC000,57.00182,51.035034,52.435081,58.501949
64,64,2,8,HPC: Gas-hexadecane PC000,Partition coefficient,#C6CEBA,512.0291139999998,467.415588,492.756042,490.01632699999993
65,65,2,9,LFI: Lipoaffinity index101,Solubility lipoaffinity,#D1963A,53.36451,52.035069,52.99231,58.83529300000001
66,66,2,10,SHA: Strong H-Bond acceptors_3010,Hydrogen bond related,#FFC000,56.37828100000001,57.835262,56.168507,63.702122
67,67,2,11,SHA: Strong H-Bond acceptors_301,Hydrogen bond related,#FFC000,119.719406,108.770294,119.971024,119.570656
68,68,2,12,SHA: Strong H-Bond acceptors_310,Hydrogen bond related,#FFC000,137.126526,137.304581,136.910736,144.438141
69,69,2,13,LFI: Lipoaffinity index000,Solubility lipoaffinity,#D1963A,413.613922,422.214081,412.793945,404.513489
70,70,2,14,SHA: Strong H-Bond acceptors_3002,Hydrogen bond related,#FFC000,60.483242,64.702156,67.92600300000001,61.368713
71,71,2,15,SHAAC: Strong H-Bond acceptors_3 transition between A and C,Hydrogen bond related,#FFC000,0.189056,0.206221,0.200791,0.200687
72,72,2,16,HPCCB: Gas-hexadecane PC_3 composition of B,Partition coefficient,#C6CEBA,0.216379,0.240183,0.216216,0.223315
73,73,2,17,HPCCB: Gas-hexadecane PC composition of B,Partition coefficient,#C6CEBA,0.216379,0.240183,0.216216,0.223315
74,74,2,18,PHB: Potential Hydrogen Bonds_3110,Hydrogen bond related,#FFC000,41.413353,48.568287,37.612839,43.134769
75,75,2,19,HPC: Gas-hexadecane PC110,Partition coefficient,#C6CEBA,42.972202,51.601719,40.120361,45.968201
76,76,2,20,SHA: Strong H-Bond acceptors_3220,Hydrogen bond related,#FFC000,24.889582,28.300943,21.620417,25.500851
77,77,2,21,PCDTT: Parallel correlation PseDN composition of TT,Nucleotide related,#ED7D31,0.055,0.064,0.049,0.053
78,78,2,22,SCDTT: Series correlation PseDN composition of TT,Nucleotide related,#ED7D31,0.061,0.071,0.054000000000000006,0.06
79,79,2,23,DPRA0: Distribution of 0.00A,Transcript related,#CCB441,0.000312,3.3e-05,0.000167,3.3e-05
80,80,2,24,SLFB0: Sum of path lengths starting from oxygens_3 distribution of 0.00B,Topological indice,#B4B044,0.000312,3.3e-05,0.000167,3.3e-05
81,81,2,25,HPCB0: Gas-hexadecane PC_3 distribution of 0.00B,Partition coefficient,#C6CEBA,0.000104,0.000167,0.000279,0.0003
82,82,2,26,PHBB0: Potential Hydrogen Bonds_3 distribution of 0.00B,Hydrogen bond related,#FFC000,0.000104,0.000167,0.000279,0.0003
83,83,2,27,DPRC0: Distribution of 0.00C,Transcript related,#CCB441,0.000104,0.000167,0.000279,0.0003
84,84,3,0,TraEY: Entropy density Y on transcript,Transcript related,#CCB441,0.040643,0.02639,0.046526,0.033006
85,85,3,1,SCDGA: Series correlation PseDN composition of GA,Nucleotide related,#ED7D31,0.063,0.043,0.065,0.054000000000000006
86,86,3,2,PCDGA: Parallel correlation PseDN composition of GA,Nucleotide related,#ED7D31,0.058,0.038,0.059,0.048
87,87,3,3,SLF: Sum of path lengths starting from oxygens_3210,Topological indice,#B4B044,25.097427,20.600687,26.524017,26.367546
88,88,3,4,PHB: Potential Hydrogen Bonds_30,Hydrogen bond related,#FFC000,587.944946,503.616791,585.645813,539.017944
89,89,3,5,MLF: Linear free energy100,Hydrogen bond related,#FFC000,133.489212,110.670357,137.245071,125.504181
90,90,3,6,MLF: Linear free energy001,Hydrogen bond related,#FFC000,133.43725600000002,110.670357,137.245071,125.504181
91,91,3,7,HPC: Gas-hexadecane PC00,Partition coefficient,#C6CEBA,631.748535,593.886475,624.3173830000002,615.5205080000002
92,92,3,8,SHA: Strong H-Bond acceptors_3100,Hydrogen bond related,#FFC000,76.227592,74.10247,74.334114,74.869164
93,93,3,9,HPCCA: Gas-hexadecane PC composition of A,Partition coefficient,#C6CEBA,0.783673,0.759851,0.78384,0.776718
94,94,3,10,SHA: Strong H-Bond acceptors_3001,Hydrogen bond related,#FFC000,66.71862800000001,60.90203100000001,62.24228299999999,63.06876800000001
95,95,3,11,SHAAB: Strong H-Bond acceptors_3 transition between A and B,Hydrogen bond related,#FFC000,0.256873,0.246091,0.25691,0.26402600000000004
96,96,3,12,LFI: Lipoaffinity index10,Solubility lipoaffinity,#D1963A,185.710571,185.872864,187.451248,192.806427
97,97,3,13,LFI: Lipoaffinity index_3002,Solubility lipoaffinity,#D1963A,49.259548,48.401615,49.927559,45.66819
98,98,3,14,LFI: Lipoaffinity index_3200,Solubility lipoaffinity,#D1963A,51.026241,60.835361,56.112782,59.668655
99,99,3,15,SHA: Strong H-Bond acceptors_3020,Hydrogen bond related,#FFC000,42.504547,43.601452,46.305584,45.468182
100,100,3,16,SHA: Strong H-Bond acceptors_302,Hydrogen bond related,#FFC000,103.247597,117.370583,108.882202,112.770424
101,101,3,17,PHBCB: Potential Hydrogen Bonds_3 composition of B,Hydrogen bond related,#FFC000,0.216379,0.240183,0.216216,0.223315
102,102,3,18,SHACC: Strong H-Bond acceptors_3 composition of C,Hydrogen bond related,#FFC000,0.216379,0.240183,0.216216,0.223315
103,103,3,19,ComRC: Composition of C,Transcript related,#CCB441,0.216368,0.240141,0.216204,0.223307
104,104,3,20,HPC: Gas-hexadecane PC011,Partition coefficient,#C6CEBA,42.972202,51.635056,40.120361,45.968201
105,105,3,21,SHA: Strong H-Bond acceptors_3022,Hydrogen bond related,#FFC000,29.306313,38.567951,29.198708,33.534451000000004
106,106,3,22,HPC: Gas-hexadecane PC_3011,Partition coefficient,#C6CEBA,25.928812,32.701092,24.573721,28.567619
107,107,3,23,HPC: Gas-hexadecane PC_3110,Partition coefficient,#C6CEBA,19.641466,26.334211,21.007467,23.300777
108,108,3,24,TraGC: Transition between G and C,Transcript related,#CCB441,0.050873,0.069971,0.05750900000000001,0.062104
109,109,3,25,MLF: Linear free energy111,Hydrogen bond related,#FFC000,63.393089,100.703354,60.013374,75.469185
110,110,3,26,PCDTC: Parallel correlation PseDN composition of TC,Nucleotide related,#ED7D31,0.006999999999999999,0.009000000000000001,0.009000000000000001,0.009000000000000001
111,111,3,27,SCDTC: Series correlation PseDN composition of TC,Nucleotide related,#ED7D31,0.008,0.01,0.01,0.01
112,112,4,0,PCDGG: Parallel correlation PseDN composition of GG,Nucleotide related,#ED7D31,0.095,0.054000000000000006,0.09,0.066
113,113,4,1,HPC: Gas-hexadecane PC_3220,Partition coefficient,#C6CEBA,48.272278,27.034235,44.02095,32.201073
114,114,4,2,SLF: Sum of path lengths starting from oxygens_3021,Topological indice,#B4B044,26.13666,21.334045,29.087261,25.867529
115,115,4,3,HPC: Gas-hexadecane PC_302,Partition coefficient,#C6CEBA,131.254868,104.136803,134.01315300000002,115.770523
116,116,4,4,MLFCA: Linear free energy composition of A,Hydrogen bond related,#FFC000,0.587975,0.503634,0.5856779999999999,0.539036
117,117,4,5,MLF: Linear free energy0,Hydrogen bond related,#FFC000,587.944946,503.616791,585.645813,539.017944
118,118,4,6,PHBCA: Potential Hydrogen Bonds_3 composition of A,Hydrogen bond related,#FFC000,0.587975,0.503634,0.5856779999999999,0.539036
119,119,4,7,SLF: Sum of path lengths starting from oxygens_3120,Topological indice,#B4B044,30.917122,28.034267,31.316172,28.934298
120,120,4,8,TraEM: Entropy density M on transcript,Transcript related,#CCB441,0.02372,0.02724,0.026247000000000003,0.023287
121,121,4,9,HPC: Gas-hexadecane PC0,Partition coefficient,#C6CEBA,783.632141,759.825317,783.795837,776.692566
122,122,4,10,PHB: Potential Hydrogen Bonds_3020,Hydrogen bond related,#FFC000,78.046249,74.735825,79.18199200000002,81.869392
123,123,4,11,LFI: Lipoaffinity index01,Solubility lipoaffinity,#D1963A,185.762543,185.839523,187.506958,192.806427
124,124,4,12,LFIAB: Lipoaffinity index transition between A and B,Solubility lipoaffinity,#D1963A,0.371512,0.371737,0.375,0.385639
125,125,4,13,ASMH1: Dinucleotide auto covariance of lag1 on SMH,Nucleotide related,#ED7D31,0.134,0.139,0.131,0.117
126,126,4,14,LFI: Lipoaffinity index0,Solubility lipoaffinity,#D1963A,731.774475,741.924744,734.8155519999998,731.291016
127,127,4,15,LFICA: Lipoaffinity index composition of A,Solubility lipoaffinity,#D1963A,0.731813,0.741949,0.734857,0.7313149999999999
128,128,4,16,LFI: Lipoaffinity index00,Solubility lipoaffinity,#D1963A,546.011963,556.05188,547.3085940000002,538.4846190000002
129,129,4,17,HPC: Gas-hexadecane PC10,Partition coefficient,#C6CEBA,151.83165,165.90553300000005,159.42271399999996,161.138702
130,130,4,18,SLF: Sum of path lengths starting from oxygens_3002,Topological indice,#B4B044,50.194855,60.30201,48.645939,57.535252
131,131,4,19,PHB: Potential Hydrogen Bonds_3101,Hydrogen bond related,#FFC000,30.033775,36.90123,25.911066,33.367779
132,132,4,20,HPC: Gas-hexadecane PC101,Partition coefficient,#C6CEBA,32.112236,39.467983,27.861362,35.634521
133,133,4,21,SHA: Strong H-Bond acceptors_3202,Hydrogen bond related,#FFC000,18.654196,22.934097,15.713807999999998,21.667389
134,134,4,22,HPC: Gas-hexadecane PC_3101,Partition coefficient,#C6CEBA,15.536503,19.100637,14.097848999999998,16.233875
135,135,4,23,PCDCT: Parallel correlation PseDN composition of CT,Nucleotide related,#ED7D31,0.037000000000000005,0.051,0.04,0.044
136,136,4,24,MLF: Linear free energy11,Hydrogen bond related,#FFC000,161.704346,226.040863,157.249527,189.972992
137,137,4,25,SLF: Sum of path lengths starting from oxygens_3000,Topological indice,#B4B044,63.393089,100.703354,60.013374,75.469185
138,138,4,26,PHBBC: Potential Hydrogen Bonds_3 transition between B and C,Hydrogen bond related,#FFC000,0.050876,0.069974,0.057512,0.062106
139,139,4,27,PHB: Potential Hydrogen Bonds_3120,Hydrogen bond related,#FFC000,3.68927,4.233474,5.683718,5.466849
140,140,5,0,HPC: Gas-hexadecane PC_3022,Partition coefficient,#C6CEBA,42.192776,25.20084,38.170067,30.701023
141,141,5,1,TPS: Topological polar surface area_3011,Topological indice,#B4B044,53.936089,31.034369,54.329655,36.167873
142,142,5,2,SCDGG: Series correlation PseDN composition of GG,Nucleotide related,#ED7D31,0.104,0.061,0.1,0.07400000000000001
143,143,5,3,HPC: Gas-hexadecane PC_3202,Partition coefficient,#C6CEBA,45.206547,29.100969,48.534492,34.601154
144,144,5,4,HPCAC: Gas-hexadecane PC_3 transition between A and C,Partition coefficient,#C6CEBA,0.27953,0.228056,0.286725,0.247925
145,145,5,5,HPC: Gas-hexadecane PC_3020,Partition coefficient,#C6CEBA,65.627434,56.301876,70.82358599999998,62.068737
146,146,5,6,HPC: Gas-hexadecane PC_3200,Partition coefficient,#C6CEBA,70.044167,68.935631,66.031425,70.669022
147,147,5,7,LFI: Lipoaffinity index_310,Solubility lipoaffinity,#D1963A,125.383217,101.903397,127.214981,107.636925
148,148,5,8,SLF: Sum of path lengths starting from oxygens_3012,Topological indice,#B4B044,33.411274,26.900896000000003,33.935139,30.234341
149,149,5,9,MLF: Linear free energy010,Hydrogen bond related,#FFC000,152.03949,145.004837,159.8685,156.50521899999995
150,150,5,10,LFIAB: Lipoaffinity index_3 transition between A and B,Solubility lipoaffinity,#D1963A,0.258899,0.223322,0.263486,0.236657
151,151,5,11,SLF: Sum of path lengths starting from oxygens_3201,Topological indice,#B4B044,35.437775,35.801193,37.612839,35.601185
152,152,5,12,ORFEW: Entropy density W on ORF,Open reading frame,#BDC6CF,0.030358,0.036692,0.0,0.029861
153,153,5,13,L1BDS: Series correlation PseDN composition of lamda1-BDS,Nucleotide related,#ED7D31,0.0201,0.0194,0.0189,0.0177
154,154,5,14,ABDG1: Dinucleotide auto covariance of lag1 on BDG,Nucleotide related,#ED7D31,0.153,0.196,0.154,0.161
155,155,5,15,LFI: Lipoaffinity index_302,Solubility lipoaffinity,#D1963A,89.010132,90.403015,94.895798,86.80289499999998
156,156,5,16,LFI: Lipoaffinity index_3020,Solubility lipoaffinity,#D1963A,49.051701,39.901329,54.38538000000001,41.601387
157,157,5,17,SLF: Sum of path lengths starting from oxygens_3200,Topological indice,#B4B044,57.05378,64.168808,57.227238,58.135273
158,158,5,18,SLF: Sum of path lengths starting from oxygens_3020,Topological indice,#B4B044,64.3284,79.169304,66.644379,73.169106
159,159,5,19,PHB: Potential Hydrogen Bonds_3021,Hydrogen bond related,#FFC000,30.605352000000003,36.301208,35.439651,34.767826
160,160,5,20,PHB: Potential Hydrogen Bonds_3102,Hydrogen bond related,#FFC000,37.100544,58.535286,37.724285,50.301678
161,161,5,21,GCCo3: GC content of 3rd position of codons,Guanine-cytosine related,#9AA983,0.408885,0.496117,0.405048,0.462515
162,162,5,22,GCCoW: GC content of whole sequence,Guanine-cytosine related,#9AA983,0.412055,0.496383,0.414354,0.460982
163,163,5,23,MLFCB: Linear free energy composition of B,Hydrogen bond related,#FFC000,0.412076,0.4964,0.4143770000000001,0.4609970000000001
164,164,5,24,SCDCT: Series correlation PseDN composition of CT,Nucleotide related,#ED7D31,0.04,0.057,0.044,0.05
165,165,5,25,SLF: Sum of path lengths starting from oxygens_300,Topological indice,#B4B044,161.704346,226.040863,157.249527,189.972992
166,166,5,26,PHB: Potential Hydrogen Bonds_3012,Hydrogen bond related,#FFC000,4.468693,4.533484,5.683718,5.000167
167,167,5,27,GCC1V: GCCo1 variance frame score,Guanine-cytosine related,#9AA983,0.000167,0.000173,0.000211,1.1e-05
168,168,6,0,SCFFS: Stop codon frequency frame score,Codon related,#679DC4,2.660675,8.760727000000001,21.274971,1.3085209999999998
169,169,6,1,TPS: Topological polar surface area_3110,Topological indice,#B4B044,43.28397,26.900896000000003,42.73933,34.234474
170,170,6,2,PSN: Primary or secondary nitrogens110,Topological indice,#B4B044,68.849052,42.268074,67.535942,50.901695
171,171,6,3,TPS: Topological polar surface area_3101,Topological indice,#B4B044,44.427124,31.73439,46.138416,37.867928000000006
172,172,6,4,HPC: Gas-hexadecane PC_320,Partition coefficient,#C6CEBA,148.24629199999995,123.904129,152.680267,132.137741
173,173,6,5,SLF: Sum of path lengths starting from oxygens_3102,Topological indice,#B4B044,32.943622999999995,30.667688,38.225788,32.701092
174,174,6,6,ORFEI: Entropy density I on ORF,Open reading frame,#BDC6CF,0.049682,0.048723,0.078934,0.0448
175,175,6,7,PHB: Potential Hydrogen Bonds_3010,Hydrogen bond related,#FFC000,73.993248,70.269012,80.686501,74.635818
176,176,6,8,PHB: Potential Hydrogen Bonds_3001,Hydrogen bond related,#FFC000,57.781242000000006,46.601555,63.523907,53.63511999999999
177,177,6,9,LFI: Lipoaffinity index_301,Solubility lipoaffinity,#D1963A,133.489212,121.404045,136.242065,129.004303
178,178,6,10,PHB: Potential Hydrogen Bonds_3100,Hydrogen bond related,#FFC000,76.48739599999998,59.635323,84.80998199999998,67.002235
179,179,6,11,nMFE,Secondary structure,#76A6D3,-0.274029,-0.357509,-0.27937,-0.323931
180,180,6,12,TraEC: Entropy density C on transcript,Transcript related,#CCB441,0.052422,0.041612,0.052077,0.041166
181,181,6,13,LFI: Lipoaffinity index_3000,Solubility lipoaffinity,#D1963A,191.842041,160.838699,180.430176,164.238815
182,182,6,14,ASMS1: Dinucleotide auto covariance of lag1 on SMS,Nucleotide related,#ED7D31,0.045,0.057,0.043,0.033
183,183,6,15,AHCT1: Dinucleotide auto covariance of lag1 on HCT,Nucleotide related,#ED7D31,0.153,0.197,0.154,0.162
184,184,6,16,LFIAC: Lipoaffinity index_3 transition between A and C,Solubility lipoaffinity,#D1963A,0.186146,0.200353,0.198841,0.194986
185,185,6,17,HPC: Gas-hexadecane PC01,Partition coefficient,#C6CEBA,151.83165,165.938858,159.42271399999996,161.138702
186,186,6,18,HPCAB: Gas-hexadecane PC transition between A and B,Partition coefficient,#C6CEBA,0.303695,0.331867,0.318881,0.322299
187,187,6,19,MLF: Linear free energy101,Hydrogen bond related,#FFC000,116.861519,159.638657,119.803856,145.47151200000005
188,188,6,20,MLF: Linear free energy011,Hydrogen bond related,#FFC000,98.259285,125.337509,97.180428,114.503815
189,189,6,21,HPC: Gas-hexadecane PC_301,Partition coefficient,#C6CEBA,91.244476,107.70359,97.12471,100.036667
190,190,6,22,SLF: Sum of path lengths starting from oxygens_30,Topological indice,#B4B044,412.055084,496.383209,414.354187,460.982025
191,191,6,23,MLF: Linear free energy1,Hydrogen bond related,#FFC000,412.055084,496.383209,414.354187,460.982025
192,192,6,24,SLFCA: Sum of path lengths starting from oxygens_3 composition of A,Topological indice,#B4B044,0.412076,0.4964,0.4143770000000001,0.4609970000000001
193,193,6,25,TraEA: Entropy density A on transcript,Transcript related,#CCB441,0.044841000000000006,0.05843200000000001,0.052319,0.052823
194,194,6,26,GCC2V: GCCo2 variance frame score,Guanine-cytosine related,#9AA983,0.000169,0.000174,0.000209,1.1e-05
195,195,6,27,GCC3V: GCCo3 variance frame score,Guanine-cytosine related,#9AA983,0.000166,0.000175,0.000209,1.2e-05
196,196,7,0,SCCFS: Stop codon count frame score,Codon related,#679DC4,259.0,931.0,2041.0,139.0
197,197,7,1,PSN: Primary or secondary nitrogens011,Topological indice,#B4B044,68.849052,42.268074,67.535942,50.901695
198,198,7,2,SLF: Sum of path lengths starting from oxygens_3022,Topological indice,#B4B044,41.569241,28.300943,42.572163,34.934498
199,199,7,3,C3UTR: Coverage of 3 untranslated region,Transcript related,#CCB441,0.583164,0.08176900000000001,0.398808,0.973666
200,200,7,4,PSN: Primary or secondary nitrogens101,Topological indice,#B4B044,69.264748,49.334976,73.05249,58.101936
201,201,7,5,ORFEY: Entropy density Y on ORF,Open reading frame,#BDC6CF,0.022391,0.021945,0.083385,0.0
202,202,7,6,LFI: Lipoaffinity index_3010,Solubility lipoaffinity,#D1963A,66.666664,51.168373,72.38382,56.768559
203,203,7,7,SHD: Strong H-Bond donors000,Hydrogen bond related,#FFC000,536.08728,439.181305,526.969788,460.282013
204,204,7,8,LFI: Lipoaffinity index_3100,Solubility lipoaffinity,#D1963A,70.719666,52.20174,68.984734,53.901798
205,205,7,9,LFI: Lipoaffinity index_3001,Solubility lipoaffinity,#D1963A,72.486359,64.60215,75.169952,67.90226
206,206,7,10,ASTB1: Dinucleotide auto covariance of lag1 on STB,Nucleotide related,#ED7D31,-0.01,-0.057,-0.031,-0.051
207,207,7,11,SHA: Strong H-Bond acceptors_3000,Hydrogen bond related,#FFC000,165.237717,150.005005,159.589874,151.205048
208,208,7,12,TraEV: Entropy density V on transcript,Transcript related,#CCB441,0.056301,0.055186,0.055736,0.060641
209,209,7,13,MRe: Molar refractivity1,Polarizability refractivity,#A0CF6D,536.08728,485.716187,536.665527,493.616455
210,210,7,14,LFI: Lipoaffinity index_300,Solubility lipoaffinity,#D1963A,313.5879520000001,273.87579300000004,305.527679,277.809265
211,211,7,15,ABLS1: Dinucleotide auto covariance of lag1 on BLS,Nucleotide related,#ED7D31,-0.08,-0.053,-0.087,-0.081
212,212,7,16,ADTB1: Dinucleotide auto covariance of lag1 on DTB,Nucleotide related,#ED7D31,0.138,0.187,0.136,0.146
213,213,7,17,LFI: Lipoaffinity index_320,Solubility lipoaffinity,#D1963A,97.116135,109.936996,103.922882,108.170273
214,214,7,18,PHB: Potential Hydrogen Bonds_3201,Hydrogen bond related,#FFC000,21.356197,23.300777,23.403543,22.467415
215,215,7,19,GCCo2: GC content of 2nd position of codons,Guanine-cytosine related,#9AA983,0.420577,0.488916,0.416583,0.458815
216,216,7,20,PHB: Potential Hydrogen Bonds_3210,Hydrogen bond related,#FFC000,28.21512,36.234543,30.201715000000004,32.934433
217,217,7,21,HPCAB: Gas-hexadecane PC_3 transition between A and B,Partition coefficient,#C6CEBA,0.165515,0.19562,0.175602,0.183718
218,218,7,22,MLF: Linear free energy110,Hydrogen bond related,#FFC000,98.311249,125.304176,97.236153,114.503815
219,219,7,23,LFI: Lipoaffinity index_3202,Solubility lipoaffinity,#D1963A,20.213043,22.200741,22.790594,20.767359
220,220,7,24,FickS: Fickett score,Codon related,#679DC4,0.368,0.4931,0.368,0.4384
221,221,7,25,TPS: Topological polar surface area_3220,Topological indice,#B4B044,24.058197,42.0014,22.957762,32.601085999999995
222,222,7,26,LFI: Lipoaffinity index_3022,Solubility lipoaffinity,#D1963A,20.057158,29.934332,19.948734,24.834162
223,223,7,27,PCDCC: Parallel correlation PseDN composition of CC,Nucleotide related,#ED7D31,0.04,0.07,0.037000000000000005,0.056
224,224,8,0,LORFL: Longest ORF length,Open reading frame,#BDC6CF,411.0,414.0,519.0,609.0
225,225,8,1,SLF: Sum of path lengths starting from oxygens_3220,Topological indice,#B4B044,46.14185300000001,30.601021000000006,48.3116,35.367847
226,226,8,2,TraEF: Entropy density F on transcript,Transcript related,#CCB441,0.060178,0.04303,0.061889,0.048594
227,227,8,3,SLFCC: Sum of path lengths starting from oxygens_3 composition of C,Topological indice,#B4B044,0.319736,0.24555,0.320479,0.270318
228,228,8,4,TPS: Topological polar surface area_310,Topological indice,#B4B044,128.033249,102.570084,131.00412,116.87056
229,229,8,5,TPS: Topological polar surface area_3010,Topological indice,#B4B044,63.23720600000001,55.03516800000001,64.192581,59.035301
230,230,8,6,TPS: Topological polar surface area_3100,Topological indice,#B4B044,69.108856,56.768559,71.436531,60.90203100000001
231,231,8,7,SHD: Strong H-Bond donors00,Hydrogen bond related,#FFC000,654.92334,569.38562,646.6622309999998,590.319702
232,232,8,8,SHD: Strong H-Bond donors0,Hydrogen bond related,#FFC000,804.312805,743.791443,801.849976,762.325439
233,233,8,9,SHAC1: Strong H-Bond acceptors_3 distriCution of 0.25C,Hydrogen bond related,#FFC000,0.229474,0.269885,0.224687,0.257184
234,234,8,10,CNH: NH- count111,Molecular fingerprint,#9AB6D1,165.237717,150.005005,159.589874,151.205048
235,235,8,11,CNH: NH- count11,Molecular fingerprint,#9AB6D1,292.439606,275.609192,289.758148,275.642517
236,236,8,12,TPSBC: Topological polar surface area_3 transition between B and C,Topological indice,#B4B044,0.13527,0.13038,0.141329,0.13288
237,237,8,13,ProAH: Pseudo protein average hydropathy,Pseudo protein related,#B3CE93,0.375735,-0.341606,2.066279,0.718812
238,238,8,14,LFICA: Lipoaffinity index_3 composition of A,Solubility lipoaffinity,#D1963A,0.536115,0.485732,0.536695,0.493633
239,239,8,15,MRe: Molar refractivity11,Polarizability refractivity,#A0CF6D,313.5879520000001,273.87579300000004,305.527679,277.809265
240,240,8,16,MRe: Molar refractivity111,Polarizability refractivity,#A0CF6D,191.842041,160.838699,180.430176,164.238815
241,241,8,17,ABDH1: Dinucleotide auto covariance of lag1 on BDH,Nucleotide related,#ED7D31,-0.009000000000000001,0.042,-0.012,0.004
242,242,8,18,ORFEA: Entropy density A on ORF,Open reading frame,#BDC6CF,0.0551,0.048723,0.046168,0.057211
243,243,8,19,TraEW: Entropy density W on transcript,Transcript related,#CCB441,0.026661,0.031912,0.02534,0.02953
244,244,8,20,GCCo1: GC content of 1st position of codons,Guanine-cytosine related,#9AA983,0.406703,0.504117,0.4214310000000001,0.461615
245,245,8,21,HPC: Gas-hexadecane PC_310,Partition coefficient,#C6CEBA,74.253052,87.90293100000002,78.457596,83.66945600000003
246,246,8,22,SLF: Sum of path lengths starting from oxygens_3100,Topological indice,#B4B044,41.205509,61.168705,39.953194,56.368546
247,247,8,23,SLF: Sum of path lengths starting from oxygens_3001,Topological indice,#B4B044,48.116394,65.002167,48.590214,56.96856700000001
248,248,8,24,ORFCo: ORF coverage,Open reading frame,#BDC6CF,0.021356,0.0138,0.02892,0.020301
249,249,8,25,TPS: Topological polar surface area_3202,Topological indice,#B4B044,12.522733,25.234175,15.435194,23.767458
250,250,8,26,TPS: Topological polar surface area_3022,Topological indice,#B4B044,17.303196,30.634354,16.215313000000002,25.467516
251,251,8,27,LFI: Lipoaffinity index_3220,Solubility lipoaffinity,#D1963A,20.78462,34.80115900000001,19.168617,29.634321000000003
252,252,9,0,EiSNR: Electron-ion interaction pseudopotential signal/noise ratio,EIIP based spectrum,#99C94D,0.100038,0.050017,0.060742,0.08451499999999999
253,253,9,1,EiPS4: Electron-ion interaction pseudopotential spectrum 1,EIIP based spectrum,#99C94D,111.912671,337.5329720000001,182.884431,210.54526600000003
254,254,9,2,TPSCB: Topological polar surface area_3 composition of B,Topological indice,#B4B044,0.319736,0.24555,0.320479,0.270318
255,255,9,3,ComRT: Composition of T,Transcript related,#CCB441,0.31971900000000003,0.245542,0.320461,0.270309
256,256,9,4,SLF: Sum of path lengths starting from oxygens_3202,Topological indice,#B4B044,48.895817,37.834595,51.432076,43.734791
257,257,9,5,TPS: Topological polar surface area_301,Topological indice,#B4B044,154.37776200000005,131.33770800000002,157.639587,136.737885
258,258,9,6,TPS: Topological polar surface area_3001,Topological indice,#B4B044,82.514938,69.202309,84.02986899999998,69.43564599999999
259,259,9,7,SHDCA: Strong H-Bond donors composition of A,Hydrogen bond related,#FFC000,0.804355,0.743816,0.801895,0.762351
260,260,9,8,DPRC1: Distribution of 0.25C,Transcript related,#CCB441,0.229462,0.269876,0.224674,0.257175
261,261,9,9,PHBB2: Potential Hydrogen Bonds_3 distribution of 0.50B,Hydrogen bond related,#FFC000,0.435408,0.483366,0.455614,0.4959
262,262,9,10,SHA: Strong H-Bond acceptors_300,Hydrogen bond related,#FFC000,292.439606,275.609192,289.758148,275.642517
263,263,9,11,SHACA: Strong H-Bond acceptors_3 composition of A,Hydrogen bond related,#FFC000,0.515433,0.501767,0.51864,0.508001
264,264,9,12,TraTG: Transition between T and G,Transcript related,#CCB441,0.13526300000000002,0.130375,0.141321,0.132876
265,265,9,13,ORFEC: Entropy density C on ORF,Open reading frame,#BDC6CF,0.0551,0.042969,0.123355,0.053295
266,266,9,14,SLFAC: Sum of path lengths starting from oxygens_3 transition between A and C,Topological indice,#B4B044,0.27345,0.266627,0.284608,0.27146
267,267,9,15,MReCB: Molar refractivity composition of B,Polarizability refractivity,#A0CF6D,0.536115,0.485732,0.536695,0.493633
268,268,9,16,PCDTG: Parallel correlation PseDN composition of TG,Nucleotide related,#ED7D31,0.067,0.067,0.069,0.066
269,269,9,17,TraTC: Transition between T and C,Transcript related,#CCB441,0.138173,0.136242,0.143271,0.138576
270,270,9,18,ORFEG: Entropy density G on ORF,Open reading frame,#BDC6CF,0.060137,0.08918999999999999,0.013434,0.06788200000000001
271,271,9,19,LFICC: Lipoaffinity index_3 composition of C,Solubility lipoaffinity,#D1963A,0.195697,0.25621700000000003,0.198161,0.237683
272,272,9,20,ComRG: Composition of G,Transcript related,#CCB441,0.195687,0.256209,0.19815,0.237675
273,273,9,21,HPC: Gas-hexadecane PC_3010,Partition coefficient,#C6CEBA,35.126007,42.501415,35.216763,40.168007
274,274,9,22,HPC: Gas-hexadecane PC_3001,Partition coefficient,#C6CEBA,42.660431,62.735424,44.912514,56.93523
275,275,9,23,SLF: Sum of path lengths starting from oxygens_3010,Topological indice,#B4B044,52.533127,80.469353,53.159477,72.302406
276,276,9,24,PHB: Potential Hydrogen Bonds_3220,Hydrogen bond related,#FFC000,24.993505,36.267876,23.737881,32.967766
277,277,9,25,SHD: Strong H-Bond donors101,Hydrogen bond related,#FFC000,30.553391,44.16814,35.49537700000001,41.934731
278,278,9,26,SHD: Strong H-Bond donors011,Hydrogen bond related,#FFC000,34.918159,56.535217,32.876408000000005,47.601585
279,279,9,27,SCDCC: Series correlation PseDN composition of CC,Nucleotide related,#ED7D31,0.043,0.078,0.041,0.063
280,280,10,0,ProMW: Pseudo protein molecular weight,Pseudo protein related,#B3CE93,14836.4494,14964.0894,19735.4249,22091.7469
281,281,10,1,EipSP: Electron-ion interaction pseudopotential signal peak,EIIP based spectrum,#99C94D,29.095728,21.682258,16.450232,37.11089000000001
282,282,10,2,HPCCC: Gas-hexadecane PC_3 composition of C,Partition coefficient,#C6CEBA,0.319736,0.24555,0.320479,0.270318
283,283,10,3,PSNCB: Primary or secondary nitrogens composition of B,Topological indice,#B4B044,0.319736,0.24555,0.320479,0.270318
284,284,10,4,TPSAB: Topological polar surface area_3 transition between A and B,Topological indice,#B4B044,0.28244,0.233923,0.28867600000000004,0.253625
285,285,10,5,PSNAB: Primary or secondary nitrogens transition between A and B,Topological indice,#B4B044,0.41771,0.364303,0.430004,0.386505
286,286,10,6,HPCB1: Gas-hexadecane PC distribution of 0.25B,Partition coefficient,#C6CEBA,0.229474,0.269885,0.224687,0.257184
287,287,10,7,HPCB1: Gas-hexadecane PC_3 distribution of 0.25B,Partition coefficient,#C6CEBA,0.229474,0.269885,0.224687,0.257184
288,288,10,8,SHAC2: Strong H-Bond acceptors_3 distriCution of 0.50C,Hydrogen bond related,#FFC000,0.435408,0.483366,0.455614,0.4959
289,289,10,9,PHBB3: Potential Hydrogen Bonds_3 distribution of 0.75B,Hydrogen bond related,#FFC000,0.67143,0.7736850000000001,0.707495,0.7668510000000001
290,290,10,10,CNHCB: NH- count composition of B,Molecular fingerprint,#9AB6D1,0.515433,0.501767,0.51864,0.508001
291,291,10,11,SCDCG: Series correlation PseDN composition of CG,Nucleotide related,#ED7D31,0.051,0.049,0.054000000000000006,0.054000000000000006
292,292,10,12,PCDCG: Parallel correlation PseDN composition of CG,Nucleotide related,#ED7D31,0.047,0.044,0.049,0.048
293,293,10,13,SCDGC: Series correlation PseDN composition of GC,Nucleotide related,#ED7D31,0.076,0.076,0.08,0.07400000000000001
294,294,10,14,SLF: Sum of path lengths starting from oxygens_302,Topological indice,#B4B044,132.034302,128.80429099999998,138.303802,133.97113000000002
295,295,10,15,LFI: Lipoaffinity index_30,Solubility lipoaffinity,#D1963A,536.08728,485.716187,536.665527,493.616455
296,296,10,16,HPCBC: Gas-hexadecane PC_3 transition between B and C,Partition coefficient,#C6CEBA,0.13818,0.136247,0.143279,0.13858099999999998
297,297,10,17,SCDTG: Series correlation PseDN composition of TG,Nucleotide related,#ED7D31,0.073,0.075,0.077,0.075
298,298,10,18,HPC: Gas-hexadecane PC_3120,Partition coefficient,#C6CEBA,34.346584,40.56802,37.835728,37.867928000000006
299,299,10,19,ORFER: Entropy density R on ORF,Open reading frame,#BDC6CF,0.030358,0.054043,0.0,0.064489
300,300,10,20,TraEG: Entropy density G on transcript,Transcript related,#CCB441,0.052308000000000014,0.07403799999999999,0.050607,0.065235
301,301,10,21,TPSCC: Topological polar surface area_3 composition of C,Topological indice,#B4B044,0.195697,0.25621700000000003,0.198161,0.237683
302,302,10,22,PHBCC: Potential Hydrogen Bonds_3 composition of C,Hydrogen bond related,#FFC000,0.195697,0.25621700000000003,0.198161,0.237683
303,303,10,23,PHB: Potential Hydrogen Bonds_3202,Hydrogen bond related,#FFC000,28.371006,40.901363,32.764961,39.334644
304,304,10,24,PSNCA: Primary or secondary nitrogens composition of A,Topological indice,#B4B044,0.680316,0.754484,0.6795760000000001,0.729715
305,305,10,25,PSN: Primary or secondary nitrogens0,Topological indice,#B4B044,680.280579,754.458496,679.538635,729.690979
306,306,10,26,PHB: Potential Hydrogen Bonds_3022,Hydrogen bond related,#FFC000,32.475967,52.501751,29.588766,44.901497
307,307,10,27,SHD: Strong H-Bond donors110,Hydrogen bond related,#FFC000,34.918159,56.535217,32.932129,47.601585
308,308,11,0,EiPS1: Electron-ion interaction pseudopotential spectrum 0.25,EIIP based spectrum,#99C94D,20.888405,38.276422,18.906831,36.545882
309,309,11,1,EiPS0: Electron-ion interaction pseudopotential spectrum 0,EIIP based spectrum,#99C94D,18.469102,33.947707,16.842603,32.336186
310,310,11,2,AROL1: Dinucleotide auto covariance of lag1 on ROL,Nucleotide related,#ED7D31,0.322,0.157,0.281,0.194
311,311,11,3,ORFEF: Entropy density F on ORF,Open reading frame,#BDC6CF,0.049682,0.021945,0.125831,0.085488
312,312,11,4,PSN: Primary or secondary nitrogens10,Topological indice,#B4B044,208.833466,182.139404,214.978271,193.239777
313,313,11,5,PHBB1: Potential Hydrogen Bonds_3 distribution of 0.25B,Hydrogen bond related,#FFC000,0.229474,0.269885,0.224687,0.257184
314,314,11,6,HPCB2: Gas-hexadecane PC distribution of 0.50B,Partition coefficient,#C6CEBA,0.435408,0.483366,0.455614,0.4959
315,315,11,7,HPCB2: Gas-hexadecane PC_3 distribution of 0.50B,Partition coefficient,#C6CEBA,0.435408,0.483366,0.455614,0.4959
316,316,11,8,LFIA1: Lipoaffinity index distribution of 0.25A,Solubility lipoaffinity,#D1963A,0.237529,0.250317,0.240624,0.24585
317,317,11,9,HPCB3: Gas-hexadecane PC_3 distribution of 0.75B,Partition coefficient,#C6CEBA,0.67143,0.7736850000000001,0.707495,0.7668510000000001
318,318,11,10,SHA: Strong H-Bond acceptors_30,Hydrogen bond related,#FFC000,515.406616,501.750061,518.6113889999998,507.983612
319,319,11,11,TPS: Topological polar surface area_3210,Topological indice,#B4B044,21.512081,20.634022,24.072216,23.600786
320,320,11,12,ORFEV: Entropy density V on ORF,Open reading frame,#BDC6CF,0.073394,0.02976,0.102676,0.088035
321,321,11,13,PCDGC: Parallel correlation PseDN composition of GC,Nucleotide related,#ED7D31,0.069,0.068,0.07200000000000001,0.066
322,322,11,14,TPS: Topological polar surface area_3012,Topological indice,#B4B044,37.204468,45.268177,39.117352,41.534718
323,323,11,15,SLF: Sum of path lengths starting from oxygens_320,Topological indice,#B4B044,141.387375,137.804596,146.272156,137.471252
324,324,11,16,HPC: Gas-hexadecane PC_3021,Partition coefficient,#C6CEBA,23.434658,22.634089000000003,25.019503,23.000767
325,325,11,17,PCDGT: Parallel correlation PseDN composition of GT,Nucleotide related,#ED7D31,0.052000000000000005,0.05,0.053,0.052000000000000005
326,326,11,18,SCDGT: Series correlation PseDN composition of GT,Nucleotide related,#ED7D31,0.057,0.056,0.059,0.059
327,327,11,19,PHB: Potential Hydrogen Bonds_310,Hydrogen bond related,#FFC000,143.62171899999996,155.071838,148.501053,150.705017
328,328,11,20,SHDAB: Strong H-Bond donors transition between A and B,Hydrogen bond related,#FFC000,0.298758,0.348768,0.310354,0.343968
329,329,11,21,SHD: Strong H-Bond donors10,Hydrogen bond related,#FFC000,149.38945,174.37248200000005,155.18778999999995,171.972397
330,330,11,22,SHDCB: Strong H-Bond donors composition of B,Hydrogen bond related,#FFC000,0.195697,0.25621700000000003,0.198161,0.237683
331,331,11,23,HPC: Gas-hexadecane PC_3100,Partition coefficient,#C6CEBA,36.736816,51.801727,38.281509,46.73489
332,332,11,24,TPS: Topological polar surface area_320,Topological indice,#B4B044,94.933746,123.570786,97.849106,115.470512
333,333,11,25,PSN: Primary or secondary nitrogens000,Topological indice,#B4B044,331.774475,439.447968,322.523132,401.246704
334,334,11,26,TPS: Topological polar surface area_3002,Topological indice,#B4B044,41.517277,55.46851700000001,42.293549,53.70179
335,335,11,27,TPSAC: Topological polar surface area_3 transition between A and C,Topological indice,#B4B044,0.16348800000000002,0.218389,0.169026,0.211088
336,336,12,0,TrLen: Transcript length,Transcript related,#CCB441,19245,29999,17946,29999
337,337,12,1,SCFre: Stop codon frequency,Codon related,#679DC4,34.363709,40.353275,29.095948,46.561471
338,338,12,2,L5UTR: Length of 5 untranslated region,Transcript related,#CCB441,7611,27132,10270,181
339,339,12,3,PSN: Primary or secondary nitrogens01,Topological indice,#B4B044,208.833466,182.139404,214.978271,193.239777
340,340,12,4,MLFB1: Linear free energy distribution of 0.25B,Hydrogen bond related,#FFC000,0.23254,0.25365,0.228253,0.250683
341,341,12,5,SLFA1: Sum of path lengths starting from oxygens_3 distribution of 0.25A,Topological indice,#B4B044,0.23254,0.25365,0.228253,0.250683
342,342,12,6,DPRC2: Distribution of 0.50C,Transcript related,#CCB441,0.435386,0.483349,0.455589,0.495883
343,343,12,7,SLFA3: Sum of path lengths starting from oxygens_3 distribution of 0.75A,Topological indice,#B4B044,0.7087399999999999,0.75245,0.735414,0.752117
344,344,12,8,SHAC3: Strong H-Bond acceptors_3 distriCution of 0.75C,Hydrogen bond related,#FFC000,0.67143,0.7736850000000001,0.707495,0.7668510000000001
345,345,12,9,ORFEM: Entropy density M on ORF,Open reading frame,#BDC6CF,0.022391,0.042969,0.02325,0.04016
346,346,12,10,CNH: NH- count1,Molecular fingerprint,#9AB6D1,515.406616,501.750061,518.6113889999998,507.983612
347,347,12,11,TPS: Topological polar surface area_3021,Topological indice,#B4B044,18.75812,18.66729,20.450239,21.267376
348,348,12,12,CNH: NH- count110,Molecular fingerprint,#9AB6D1,127.201874,125.604187,130.168289,124.437485
349,349,12,13,TPS: Topological polar surface area_3120,Topological indice,#B4B044,38.347622,36.067867,40.398975,34.001133
350,350,12,14,PSN: Primary or secondary nitrogens010,Topological indice,#B4B044,139.984406,139.871323,147.442322,142.338074
351,351,12,15,TraEL: Entropy density L on transcript,Transcript related,#CCB441,0.094086,0.08541499999999999,0.092619,0.08699
352,352,12,16,MRe: Molar refractivity011,Polarizability refractivity,#A0CF6D,121.745911,113.037102,125.097511,113.57045
353,353,12,17,HPC: Gas-hexadecane PC_3012,Partition coefficient,#C6CEBA,30.189659,32.501083,37.334225,31.301043
354,354,12,18,HPC: Gas-hexadecane PC_3210,Partition coefficient,#C6CEBA,19.48558,19.067303,22.233366,20.200674
355,355,12,19,PHB: Potential Hydrogen Bonds_301,Hydrogen bond related,#FFC000,109.171211,106.803558,112.838516,109.470314
356,356,12,20,TraEH: Entropy density H on transcript,Transcript related,#CCB441,0.044458,0.03877,0.041482,0.040394
357,357,12,21,((.(,Secondary structure,#76A6D3,0.116749,0.128197,0.111868,0.124094
358,358,12,22,SHD: Strong H-Bond donors01,Hydrogen bond related,#FFC000,149.337494,174.37248200000005,155.13206499999995,171.972397
359,359,12,23,.(.,Secondary structure,#76A6D3,0.007851,0.012169,0.010001,0.011097
360,360,12,24,PSN: Primary or secondary nitrogens00,Topological indice,#B4B044,471.395172,572.285767,464.504639,536.417908
361,361,12,25,TPS: Topological polar surface area_3200,Topological indice,#B4B044,54.97531899999999,67.9356,54.942604,62.268742
362,362,12,26,TPS: Topological polar surface area_302,Topological indice,#B4B044,68.537285,94.803162,71.157921,95.603188
363,363,12,27,TraER: Entropy density R on transcript,Transcript related,#CCB441,0.048675,0.058366,0.048724,0.059409
364,364,13,0,EiPS3: Electron-ion interaction pseudopotential spectrum 0.75,EIIP based spectrum,#99C94D,29.767212,56.40976800000001,27.960822,52.859584
365,365,13,1,EiPS2: Electron-ion interaction pseudopotential spectrum 0.5,EIIP based spectrum,#99C94D,24.097397,44.676743,22.028035,42.275921
366,366,13,2,SHDB1: Strong H-Bond donors distribution of 0.25B,Hydrogen bond related,#FFC000,0.235398,0.245816,0.233881,0.244316
367,367,13,3,LFIC1: Lipoaffinity index_3 distriCution of 0.25C,Solubility lipoaffinity,#D1963A,0.235398,0.245816,0.233881,0.244316
368,368,13,4,PHBC1: Potential Hydrogen Bonds_3 distriCution of 0.25C,Hydrogen bond related,#FFC000,0.235398,0.245816,0.233881,0.244316
369,369,13,5,SLFA2: Sum of path lengths starting from oxygens_3 distribution of 0.50A,Topological indice,#B4B044,0.463833,0.474365,0.483199,0.485366
370,370,13,6,MLFB2: Linear free energy distribution of 0.50B,Hydrogen bond related,#FFC000,0.463833,0.474365,0.483199,0.485366
371,371,13,7,HPCB3: Gas-hexadecane PC distribution of 0.75B,Partition coefficient,#C6CEBA,0.67143,0.7736850000000001,0.707495,0.7668510000000001
372,372,13,8,DPRC3: Distribution of 0.75C,Transcript related,#CCB441,0.671395,0.773626,0.7074560000000001,0.766826
373,373,13,9,CC105: Cross covariance of lag1 on PID-SLI,Nucleotide related,#ED7D31,0.266,0.195,0.292,0.231
374,374,13,10,MRe: Molar refractivity101,Polarizability refractivity,#A0CF6D,115.718369,91.069702,126.769196,98.369949
375,375,13,11,HPC: Gas-hexadecane PC_3201,Partition coefficient,#C6CEBA,32.995583,25.867529,38.114342,26.867561
376,376,13,12,CNH: NH- count011,Molecular fingerprint,#9AB6D1,127.201874,125.604187,130.112564,124.437485
377,377,13,13,CC115: Cross covariance of lag1 on ETI-SLI,Nucleotide related,#ED7D31,-0.126,-0.135,-0.126,-0.11
378,378,13,14,PSN: Primary or secondary nitrogens100,Topological indice,#B4B044,139.568726,132.804428,141.925781,135.137833
379,379,13,15,PSN: Primary or secondary nitrogens001,Topological indice,#B4B044,139.568726,132.804428,141.925781,135.137833
380,380,13,16,MRe: Molar refractivity110,Polarizability refractivity,#A0CF6D,121.745911,113.003769,125.097511,113.57045
381,381,13,17,HPC: Gas-hexadecane PC010,Partition coefficient,#C6CEBA,108.859444,114.30381,119.302353,115.170509
382,382,13,18,HPC: Gas-hexadecane PC001,Partition coefficient,#C6CEBA,119.667442,126.470879,131.56135600000002,125.504181
383,383,13,19,PHBAB: Potential Hydrogen Bonds_3 transition between A and B,Hydrogen bond related,#FFC000,0.252819,0.261893,0.261369,0.260193
384,384,13,20,ORFEH: Entropy density H on ORF,Open reading frame,#BDC6CF,0.060137,0.042969,0.0317,0.0448
385,385,13,21,TraET: Entropy density T on transcript,Transcript related,#CCB441,0.055215,0.052504,0.05268,0.053468
386,386,13,22,.((,Secondary structure,#76A6D3,0.25844,0.253513,0.264826,0.252854
387,387,13,23,(.((,Secondary structure,#76A6D3,0.118276,0.128602,0.113523,0.1244
388,388,13,24,(.(,Secondary structure,#76A6D3,0.09487,0.107796,0.092267,0.103123
389,389,13,25,..(.,Secondary structure,#76A6D3,0.00543,0.00546,0.006072,0.005822
390,390,13,26,.(.(,Secondary structure,#76A6D3,0.006279,0.010616,0.008648000000000001,0.008784
391,391,13,27,TPS: Topological polar surface area_3020,Topological indice,#B4B044,32.475967,45.501518,34.492367,48.868294
392,392,14,0,Base pairs,Secondary structure,#76A6D3,5826,9675,5465,9568
393,393,14,1,SCCou: Stop codon count,Codon related,#679DC4,339.0,416.0,285.0,480.0
394,394,14,2,TPSC1: Topological polar surface area_3 distriCution of 0.25C,Topological indice,#B4B044,0.235398,0.245816,0.233881,0.244316
395,395,14,3,DPRG1: Distribution of 0.25G,Transcript related,#CCB441,0.235386,0.245808,0.233868,0.244308
396,396,14,4,PSNA1: Primary or secondary nitrogens distribution of 0.25A,Topological indice,#B4B044,0.253118,0.251617,0.24642,0.254884
397,397,14,5,C5UTR: Coverage of 5 untranslated region,Transcript related,#CCB441,0.395479,0.90443,0.572272,0.006034
398,398,14,6,MLFB3: Linear free energy distribution of 0.75B,Hydrogen bond related,#FFC000,0.7087399999999999,0.75245,0.735414,0.752117
399,399,14,7,LFIA2: Lipoaffinity index distribution of 0.50A,Solubility lipoaffinity,#D1963A,0.479994,0.488799,0.492672,0.490733
400,400,14,8,LFI: Lipoaffinity index_3102,Solubility lipoaffinity,#D1963A,19.537542,19.800659,22.177645,20.367346
401,401,14,9,HPC: Gas-hexadecane PC_3102,Partition coefficient,#C6CEBA,21.979734,17.000566,26.022512,20.667356
402,402,14,10,MRe: Molar refractivity01,Polarizability refractivity,#A0CF6D,222.499344,211.840393,231.137863,215.80719
403,403,14,11,MReAB: Molar refractivity transition between A and B,Polarizability refractivity,#A0CF6D,0.445045,0.423676,0.462327,0.4316430000000001
404,404,14,12,PCDl1: Parallel correlation PseDN composition of lamda1,Nucleotide related,#ED7D31,0.0696,0.0691,0.0712,0.0699
405,405,14,13,CC110: Cross covariance of lag1 on BDS-SLI,Nucleotide related,#ED7D31,-0.127,-0.122,-0.123,-0.1
406,406,14,14,CC125: Cross covariance of lag1 on WCI-SLI,Nucleotide related,#ED7D31,-0.126,-0.135,-0.126,-0.11
407,407,14,15,ORFEL: Entropy density L on ORF,Open reading frame,#BDC6CF,0.10172,0.092089,0.154532,0.10714
408,408,14,16,CNH: NH- count101,Molecular fingerprint,#9AB6D1,98.882828,101.436714,102.474091,109.170303
409,409,14,17,PCDl2: Parallel correlation PseDN composition of lamda2,Nucleotide related,#ED7D31,0.07200000000000001,0.0726,0.073,0.0723
410,410,14,18,SHA: Strong H-Bond acceptors_3102,Hydrogen bond related,#FFC000,24.058197,29.734325,25.242393,29.734325
411,411,14,19,HPC: Gas-hexadecane PC100,Partition coefficient,#C6CEBA,119.719406,126.437546,131.50563,125.470848
412,412,14,20,SHA: Strong H-Bond acceptors_3120,Hydrogen bond related,#FFC000,18.394388,16.933897,23.960772,16.933897
413,413,14,21,TraAC: Transition between A and C,Transcript related,#CCB441,0.114633,0.125642,0.118083,0.121608
414,414,14,22,...,Secondary structure,#76A6D3,0.555614,0.412499,0.530638,0.436192
415,415,14,23,(((.,Secondary structure,#76A6D3,0.296793,0.287635,0.306164,0.28853
416,416,14,24,(.,Secondary structure,#76A6D3,0.211604,0.211888,0.217285,0.210679
417,417,14,25,.((.,Secondary structure,#76A6D3,0.038351,0.038722,0.039742,0.037279
418,418,14,26,.(..,Secondary structure,#76A6D3,0.003903,0.005055,0.004416,0.005515
419,419,14,27,(.(.,Secondary structure,#76A6D3,0.004751,0.010211,0.006992,0.008477
420,420,15,0,EipAP: Electron-ion interaction pseudopotential average power,EIIP based spectrum,#99C94D,290.846292,433.494688,270.81998,439.103352
421,421,15,1,PHBC2: Potential Hydrogen Bonds_3 distriCution of 0.50C,Hydrogen bond related,#FFC000,0.499792,0.465498,0.511786,0.473365
422,422,15,2,LFIC2: Lipoaffinity index_3 distriCution of 0.50C,Solubility lipoaffinity,#D1963A,0.499792,0.465498,0.511786,0.473365
423,423,15,3,SHDB2: Strong H-Bond donors distribution of 0.50B,Hydrogen bond related,#FFC000,0.499792,0.465498,0.511786,0.473365
424,424,15,4,PSNA3: Primary or secondary nitrogens distribution of 0.75A,Topological indice,#B4B044,0.7512989999999999,0.747583,0.75893,0.753184
425,425,15,5,TPSC3: Topological polar surface area_3 distriCution of 0.75C,Topological indice,#B4B044,0.742725,0.731382,0.764948,0.737082
426,426,15,6,PSNA2: Primary or secondary nitrogens distribution of 0.50A,Topological indice,#B4B044,0.500312,0.4928,0.499136,0.500533
427,427,15,7,CC126: Cross covariance of lag1 on SLI-PID,Nucleotide related,#ED7D31,0.239,0.224,0.251,0.243
428,428,15,8,CC103: Cross covariance of lag1 on PID-SKE,Nucleotide related,#ED7D31,0.27,0.201,0.28,0.203
429,429,15,9,MRe: Molar refractivity010,Polarizability refractivity,#A0CF6D,100.753441,98.803291,106.040344,102.23674
430,430,15,10,LFI: Lipoaffinity index_3201,Solubility lipoaffinity,#D1963A,25.876852,26.900896000000003,25.019503,27.734259
431,431,15,11,MRe: Molar refractivity10,Polarizability refractivity,#A0CF6D,222.499344,211.807053,231.137863,215.80719
432,432,15,12,(,Secondary structure,#76A6D3,1.0,1.0,1.0,1.0
433,433,15,13,((,Secondary structure,#76A6D3,1.0,1.0,1.0,1.0
434,434,15,14,CC210: Cross covariance of lag2 on BDS-SLI,Nucleotide related,#ED7D31,-0.017,-0.022,-0.005,-0.01
435,435,15,15,CC215: Cross covariance of lag2 on ETI-SLI,Nucleotide related,#ED7D31,-0.018000000000000002,-0.026,-0.011,-0.014
436,436,15,16,CNH: NH- count01,Molecular fingerprint,#9AB6D1,222.915039,226.140869,228.797501,232.34108
437,437,15,17,CNH: NH- count10,Molecular fingerprint,#9AB6D1,222.96701,226.140869,228.853226,232.34108
438,438,15,18,CNH: NH- count010,Molecular fingerprint,#9AB6D1,95.713173,100.536682,98.684944,107.903595
439,439,15,19,MLF: Linear free energy10,Hydrogen bond related,#FFC000,250.350739,270.309021,257.104645,271.009033
440,440,15,20,SHA: Strong H-Bond acceptors_3021,Hydrogen bond related,#FFC000,31.436737,35.201172,33.377911,33.767792
441,441,15,21,SCDAT: Series correlation PseDN composition of AT,Nucleotide related,#ED7D31,0.046,0.047,0.048,0.047
442,442,15,22,PCDAT: Parallel correlation PseDN composition of AT,Nucleotide related,#ED7D31,0.042,0.042,0.043,0.041
443,443,15,23,..,Secondary structure,#76A6D3,0.5778310000000001,0.455029,0.563983,0.476528
444,444,15,24,..(,Secondary structure,#76A6D3,0.171421,0.157886,0.182561,0.160828
445,445,15,25,((.,Secondary structure,#76A6D3,0.25844,0.253435,0.264826,0.252854
446,446,15,26,.(((,Secondary structure,#76A6D3,0.296793,0.287736,0.306164,0.28853
447,447,15,27,.(,Secondary structure,#76A6D3,0.211604,0.21195,0.217285,0.210679
448,448,16,0,L3UTR: Length of 3 untranslated region,Transcript related,#CCB441,11223,2453,7157,29209
449,449,16,1,TPSC2: Topological polar surface area_3 distriCution of 0.50C,Topological indice,#B4B044,0.499792,0.465498,0.511786,0.473365
450,450,16,2,DPRG2: Distribution of 0.50G,Transcript related,#CCB441,0.499766,0.465482,0.511757,0.473349
451,451,16,3,PHBC3: Potential Hydrogen Bonds_3 distriCution of 0.75C,Hydrogen bond related,#FFC000,0.742725,0.731382,0.764948,0.737082
452,452,16,4,DPRG3: Distribution of 0.75G,Transcript related,#CCB441,0.742686,0.731358,0.7649060000000001,0.737058
453,453,16,5,LFIC3: Lipoaffinity index_3 distriCution of 0.75C,Solubility lipoaffinity,#D1963A,0.742725,0.731382,0.764948,0.737082
454,454,16,6,CC104: Cross covariance of lag1 on PID-WCI,Nucleotide related,#ED7D31,0.179,0.147,0.173,0.139
455,455,16,7,ALBZ2: Dinucleotide auto covariance of lag2 on LBZ,Nucleotide related,#ED7D31,-0.011,-0.05,0.003,-0.038
456,456,16,8,ARIS2: Dinucleotide auto covariance of lag2 on RIS,Nucleotide related,#ED7D31,-0.019,-0.057,0.006999999999999999,-0.031
457,457,16,9,ASEZ2: Dinucleotide auto covariance of lag2 on SEZ,Nucleotide related,#ED7D31,0.023,0.026,0.042,0.032
458,458,16,10,ATWI2: Dinucleotide auto covariance of lag2 on TWI,Nucleotide related,#ED7D31,0.006999999999999999,0.018000000000000002,0.028,0.03
459,459,16,11,ASLI2: Dinucleotide auto covariance of lag2 on SLI,Nucleotide related,#ED7D31,0.006999999999999999,0.015,0.035,0.03
460,460,16,12,AAPH2: Dinucleotide auto covariance of lag2 on APH,Nucleotide related,#ED7D31,0.024,0.014,0.008,0.01
461,461,16,13,(((,Secondary structure,#76A6D3,1.0,1.0,1.0,1.0
462,462,16,14,SHAC4: Strong H-Bond acceptors_3 distriCution of 1.00C,Hydrogen bond related,#FFC000,0.99948,1.000033,1.0,1.0
463,463,16,15,SLFA4: Sum of path lengths starting from oxygens_3 distribution of 1.00A,Topological indice,#B4B044,0.999844,1.000033,1.0,1.0
464,464,16,16,MLFB4: Linear free energy distribution of 1.00B,Hydrogen bond related,#FFC000,0.999844,1.000033,1.0,1.0
465,465,16,17,SHA: Strong H-Bond acceptors_3201,Hydrogen bond related,#FFC000,16.160042,14.400479999999998,20.394516,16.667223
466,466,16,18,ASFB1: Dinucleotide auto covariance of lag1 on SFB,Nucleotide related,#ED7D31,-0.036000000000000004,-0.003,-0.026,-0.005
467,467,16,19,CC129: Cross covariance of lag1 on SLI-SKE,Nucleotide related,#ED7D31,-0.24,-0.214,-0.247,-0.221
468,468,16,20,CC127: Cross covariance of lag1 on SLI-BDS,Nucleotide related,#ED7D31,-0.118,-0.125,-0.103,-0.113
469,469,16,21,PCDTA: Parallel correlation PseDN composition of TA,Nucleotide related,#ED7D31,0.057,0.066,0.058,0.063
470,470,16,22,SHABC: Strong H-Bond acceptors_3 transition between B and C,Hydrogen bond related,#FFC000,0.114639,0.125646,0.11809,0.12161199999999997
471,471,16,23,ORFET: Entropy density T on ORF,Open reading frame,#BDC6CF,0.073394,0.063612,0.0,0.035202
472,472,16,24,....,Secondary structure,#76A6D3,0.555405,0.384693,0.514259,0.410683
473,473,16,25,(...,Secondary structure,#76A6D3,0.164941,0.146396,0.17865699999999998,0.151363
474,474,16,26,..((,Secondary structure,#76A6D3,0.216867,0.197857,0.232383,0.201409
475,475,16,27,(..(,Secondary structure,#76A6D3,0.057356,0.056819000000000015,0.059798,0.055765
476,476,17,0,APIA1: Dinucleotide auto covariance of lag1 on PIA,Nucleotide related,#ED7D31,0.443,0.418,0.416,0.397
477,477,17,1,CC114: Cross covariance of lag1 on ETI-WCI,Nucleotide related,#ED7D31,0.443,0.418,0.416,0.397
478,478,17,2,SHDB3: Strong H-Bond donors distribution of 0.75B,Hydrogen bond related,#FFC000,0.742725,0.731382,0.764948,0.737082
479,479,17,3,ABST1: Dinucleotide auto covariance of lag1 on BST,Nucleotide related,#ED7D31,0.022,-0.028,0.005,-0.022
480,480,17,4,TPS: Topological polar surface area_3102,Topological indice,#B4B044,14.497272,14.067135999999998,13.429176000000002,18.100603
481,481,17,5,CC113: Cross covariance of lag1 on ETI-SKE,Nucleotide related,#ED7D31,0.263,0.239,0.242,0.239
482,482,17,6,CC101: Cross covariance of lag1 on PID-BDS,Nucleotide related,#ED7D31,0.149,0.138,0.14400000000000002,0.125
483,483,17,7,CC102: Cross covariance of lag1 on PID-ETI,Nucleotide related,#ED7D31,0.179,0.147,0.173,0.139
484,484,17,8,APID2: Dinucleotide auto covariance of lag2 on PID,Nucleotide related,#ED7D31,0.019,0.023,0.022,0.027000000000000003
485,485,17,9,ATIL2: Dinucleotide auto covariance of lag2 on TIL,Nucleotide related,#ED7D31,-0.001,-0.019,0.015,0.001
486,486,17,10,APDT2: Dinucleotide auto covariance of lag2 on PDT,Nucleotide related,#ED7D31,-0.002,0.015,0.022,0.031
487,487,17,11,CC220: Cross covariance of lag2 on SKE-SLI,Nucleotide related,#ED7D31,-0.006999999999999999,-0.016,0.006999999999999999,0.001
488,488,17,12,AIBA2: Dinucleotide auto covariance of lag2 on IBA,Nucleotide related,#ED7D31,0.024,0.014,0.008,0.01
489,489,17,13,((((,Secondary structure,#76A6D3,1.0,1.0,1.0,1.0
490,490,17,14,CC225: Cross covariance of lag2 on WCI-SLI,Nucleotide related,#ED7D31,-0.018000000000000002,-0.026,-0.011,-0.014
491,491,17,15,DPRG4: Distribution of 1.00G,Transcript related,#CCB441,0.999792,0.999833,0.999498,0.9999
492,492,17,16,HPCB4: Gas-hexadecane PC distribution of 1.00B,Partition coefficient,#C6CEBA,0.99948,1.000033,1.0,1.0
493,493,17,17,LFIC4: Lipoaffinity index_3 distriCution of 1.00C,Solubility lipoaffinity,#D1963A,0.999844,0.999867,0.999554,0.999933
494,494,17,18,CNHAB: NH- count transition between A and B,Molecular fingerprint,#9AB6D1,0.445928,0.452312,0.4577020000000001,0.464713
495,495,17,19,TPS: Topological polar surface area_3201,Topological indice,#B4B044,27.435698,30.401012,27.471302,29.434315
496,496,17,20,MLF: Linear free energy01,Hydrogen bond related,#FFC000,250.298782,270.342346,257.04892,271.009033
497,497,17,21,CC130: Cross covariance of lag1 on SLI-WCI,Nucleotide related,#ED7D31,-0.134,-0.131,-0.118,-0.125
498,498,17,22,SCDTA: Series correlation PseDN composition of TA,Nucleotide related,#ED7D31,0.062,0.07400000000000001,0.064,0.071
499,499,17,23,TPS: Topological polar surface area_3000,Topological indice,#B4B044,137.54222099999998,147.37158200000005,126.15625,136.47122199999998
500,500,17,24,TPS: Topological polar surface area_300,Topological indice,#B4B044,261.626404,272.07574500000004,252.535385,259.641998
501,501,17,25,.,Secondary structure,#76A6D3,0.651648,0.5503359999999999,0.641903,0.567673
502,502,17,26,...(,Secondary structure,#76A6D3,0.164941,0.14649700000000002,0.17865699999999998,0.151363
503,503,17,27,(..,Secondary structure,#76A6D3,0.171421,0.157808,0.182561,0.160748
504,504,18,0,AETI1: Dinucleotide auto covariance of lag1 on ETI,Nucleotide related,#ED7D31,0.443,0.418,0.416,0.397
505,505,18,1,CC107: Cross covariance of lag1 on BDS-ETI,Nucleotide related,#ED7D31,0.418,0.41,0.385,0.379
506,506,18,2,APTW1: Dinucleotide auto covariance of lag1 on PTW,Nucleotide related,#ED7D31,0.301,0.28800000000000003,0.271,0.268
507,507,18,3,ASKE1: Dinucleotide auto covariance of lag1 on SKE,Nucleotide related,#ED7D31,0.022,-0.028,0.006,-0.021
508,508,18,4,L1SKE: Series correlation PseDN composition of lamda1-SKE,Nucleotide related,#ED7D31,0.0032,-0.0011,0.0021,-0.0003
509,509,18,5,CC108: Cross covariance of lag1 on BDS-SKE,Nucleotide related,#ED7D31,0.245,0.254,0.226,0.242
510,510,18,6,L2SKE: Series correlation PseDN composition of lamda2-SKE,Nucleotide related,#ED7D31,0.001,-0.0023,-0.0003,-0.002
511,511,18,7,ADDT2: Dinucleotide auto covariance of lag2 on DDT,Nucleotide related,#ED7D31,0.004,-0.041,-0.019,-0.049
512,512,18,8,AHTF2: Dinucleotide auto covariance of lag2 on HTF,Nucleotide related,#ED7D31,-0.011,-0.05,0.003,-0.038
513,513,18,9,L2PID: Series correlation PseDN composition of lamda2-PID,Nucleotide related,#ED7D31,0.0017,0.0014,0.0018,0.0019
514,514,18,10,L2SLI: Series correlation PseDN composition of lamda2-SLI,Nucleotide related,#ED7D31,0.0003,0.0009,0.0017,0.0015
515,515,18,11,AABA1: Dinucleotide auto covariance of lag1 on ABA,Nucleotide related,#ED7D31,0.023,0.001,0.017,0.01
516,516,18,12,ASFB2: Dinucleotide auto covariance of lag2 on SFB,Nucleotide related,#ED7D31,0.015,0.006999999999999999,0.016,0.016
517,517,18,13,CC229: Cross covariance of lag2 on SLI-SKE,Nucleotide related,#ED7D31,0.008,-0.013,0.039,-0.008
518,518,18,14,CC230: Cross covariance of lag2 on SLI-WCI,Nucleotide related,#ED7D31,-0.005,-0.023,0.011,-0.017
519,519,18,15,CC228: Cross covariance of lag2 on SLI-ETI,Nucleotide related,#ED7D31,-0.005,-0.023,0.011,-0.017
520,520,18,16,TPSC4: Topological polar surface area_3 distriCution of 1.00C,Topological indice,#B4B044,0.999844,0.999867,0.999554,0.999933
521,521,18,17,PHBC4: Potential Hydrogen Bonds_3 distriCution of 1.00C,Hydrogen bond related,#FFC000,0.999844,0.999867,0.999554,0.999933
522,522,18,18,CC226: Cross covariance of lag2 on SLI-PID,Nucleotide related,#ED7D31,0.005,-0.021,-0.015,-0.029
523,523,18,19,APDT1: Dinucleotide auto covariance of lag1 on PDT,Nucleotide related,#ED7D31,-0.4370000000000001,-0.398,-0.46,-0.4270000000000001
524,524,18,20,ASLI1: Dinucleotide auto covariance of lag1 on SLI,Nucleotide related,#ED7D31,-0.32299999999999995,-0.229,-0.35100000000000003,-0.273
525,525,18,21,MLFAB: Linear free energy transition between A and B,Hydrogen bond related,#FFC000,0.5007020000000001,0.540687,0.514211,0.542054
526,526,18,22,SHA: Strong H-Bond acceptors_3012,Hydrogen bond related,#FFC000,24.369967000000006,19.967333,26.301126,21.300711
527,527,18,23,SHA: Strong H-Bond acceptors_3210,Hydrogen bond related,#FFC000,37.204468,45.134838,40.621864,44.301476
528,528,18,24,CNH: NH- count0,Molecular fingerprint,#9AB6D1,484.593414,498.249939,481.388611,492.016388
529,529,18,25,CNH: NH- count000,Molecular fingerprint,#9AB6D1,137.54222099999998,147.37158200000005,126.15625,136.47122199999998
530,530,18,26,CNH: NH- count00,Molecular fingerprint,#9AB6D1,261.626404,272.07574500000004,252.535385,259.641998
531,531,18,27,((..,Secondary structure,#76A6D3,0.218395,0.19816,0.234039,0.201614
532,532,19,0,AWCI1: Dinucleotide auto covariance of lag1 on WCI,Nucleotide related,#ED7D31,0.443,0.418,0.416,0.397
533,533,19,1,CC109: Cross covariance of lag1 on BDS-WCI,Nucleotide related,#ED7D31,0.418,0.41,0.385,0.379
534,534,19,2,CC119: Cross covariance of lag1 on SKE-WCI,Nucleotide related,#ED7D31,0.28,0.227,0.281,0.228
535,535,19,3,L1ETI: Series correlation PseDN composition of lamda1-ETI,Nucleotide related,#ED7D31,0.0235,0.0201,0.0224,0.0197
536,536,19,4,CC124: Cross covariance of lag1 on WCI-SKE,Nucleotide related,#ED7D31,0.263,0.239,0.242,0.239
537,537,19,5,L1WCI: Series correlation PseDN composition of lamda1-WCI,Nucleotide related,#ED7D31,0.0235,0.0201,0.0224,0.0197
538,538,19,6,L2WCI: Series correlation PseDN composition of lamda2-WCI,Nucleotide related,#ED7D31,0.0044,0.0011,0.0024,0.0001
539,539,19,7,ASKE2: Dinucleotide auto covariance of lag2 on SKE,Nucleotide related,#ED7D31,-0.024,-0.054000000000000006,-0.045,-0.058
540,540,19,8,ASTB2: Dinucleotide auto covariance of lag2 on STB,Nucleotide related,#ED7D31,-0.006999999999999999,-0.021,-0.026,-0.026
541,541,19,9,CC116: Cross covariance of lag1 on SKE-PID,Nucleotide related,#ED7D31,0.215,0.211,0.218,0.212
542,542,19,10,ABLS2: Dinucleotide auto covariance of lag2 on BLS,Nucleotide related,#ED7D31,0.009000000000000001,-0.014,0.019,0.001
543,543,19,11,ASDH1: Dinucleotide auto covariance of lag1 on SDH,Nucleotide related,#ED7D31,-0.095,-0.124,-0.11,-0.117
544,544,19,12,ASHI2: Dinucleotide auto covariance of lag2 on SHI,Nucleotide related,#ED7D31,0.009000000000000001,0.001,0.003,0.01
545,545,19,13,SHAB4: Strong H-Bond acceptors_3 distribution of 1.00B,Hydrogen bond related,#FFC000,1.000052,0.999933,1.000056,1.000033
546,546,19,14,ABDT2: Dinucleotide auto covariance of lag2 on BDT,Nucleotide related,#ED7D31,-0.005,-0.012,-0.027000000000000003,-0.003
547,547,19,15,CC227: Cross covariance of lag2 on SLI-BDS,Nucleotide related,#ED7D31,-0.008,-0.018000000000000002,0.011,-0.011
548,548,19,16,SHAA4: Strong H-Bond acceptors_3 distribution of 1.00A,Hydrogen bond related,#FFC000,0.999844,0.999867,0.999944,0.999933
549,549,19,17,SHDB4: Strong H-Bond donors distribution of 1.00B,Hydrogen bond related,#FFC000,0.999844,0.999867,0.999554,0.999933
550,550,19,18,PHBB4: Potential Hydrogen Bonds_3 distribution of 1.00B,Hydrogen bond related,#FFC000,0.99948,1.000033,1.0,1.0
551,551,19,19,ProII: Pseudo protein instability index,Pseudo protein related,#B3CE93,39.530882,40.932117,34.560523,42.721782
552,552,19,20,L1SLI: Series correlation PseDN composition of lamda1-SLI,Nucleotide related,#ED7D31,-0.0151,-0.0108,-0.0167,-0.0131
553,553,19,21,ATIL1: Dinucleotide auto covariance of lag1 on TIL,Nucleotide related,#ED7D31,-0.16699999999999998,-0.133,-0.18600000000000005,-0.152
554,554,19,22,CC128: Cross covariance of lag1 on SLI-ETI,Nucleotide related,#ED7D31,-0.134,-0.131,-0.118,-0.125
555,555,19,23,CNH: NH- count001,Molecular fingerprint,#9AB6D1,124.032219,124.670822,126.323418,123.137436
556,556,19,24,TPSCA: Topological polar surface area_3 composition of A,Topological indice,#B4B044,0.484619,0.498267,0.481415,0.492033
557,557,19,25,CNHCA: NH- count composition of A,Molecular fingerprint,#9AB6D1,0.484619,0.498267,0.481415,0.492033
558,558,19,26,TPS: Topological polar surface area_30,Topological indice,#B4B044,484.593414,498.249939,481.388611,492.016388
559,560,20,0,ADGC1: Dinucleotide auto covariance of lag1 on DGC,Nucleotide related,#ED7D31,0.443,0.418,0.416,0.397
560,561,20,1,ASMG1: Dinucleotide auto covariance of lag1 on SMG,Nucleotide related,#ED7D31,0.277,0.269,0.271,0.254
561,562,20,2,CC118: Cross covariance of lag1 on SKE-ETI,Nucleotide related,#ED7D31,0.28,0.227,0.281,0.228
562,563,20,3,CC224: Cross covariance of lag2 on WCI-SKE,Nucleotide related,#ED7D31,-0.011,-0.016,-0.045,-0.036000000000000004
563,564,20,4,CC213: Cross covariance of lag2 on ETI-SKE,Nucleotide related,#ED7D31,-0.011,-0.016,-0.045,-0.036000000000000004
564,565,20,5,CC208: Cross covariance of lag2 on BDS-SKE,Nucleotide related,#ED7D31,-0.01,-0.024,-0.039,-0.037000000000000005
565,566,20,6,L2ETI: Series correlation PseDN composition of lamda2-ETI,Nucleotide related,#ED7D31,0.0044,0.0011,0.0024,0.0001
566,567,20,7,L2BDS: Series correlation PseDN composition of lamda2-BDS,Nucleotide related,#ED7D31,0.0028,-0.0,0.0015,-0.0009
567,568,20,8,ABST2: Dinucleotide auto covariance of lag2 on BST,Nucleotide related,#ED7D31,-0.024,-0.054000000000000006,-0.046,-0.058
568,569,20,9,CC121: Cross covariance of lag1 on WCI-PID,Nucleotide related,#ED7D31,0.129,0.141,0.127,0.132
569,570,20,10,ProPI: Pseudo protein isoelectric point,Pseudo protein related,#B3CE93,9.116813,6.948305,6.71231,9.076133
570,571,20,11,ASDS1: Dinucleotide auto covariance of lag1 on SDS,Nucleotide related,#ED7D31,-0.069,-0.101,-0.103,-0.099
571,572,20,12,ASHI1: Dinucleotide auto covariance of lag1 on SHI,Nucleotide related,#ED7D31,-0.012,-0.013,0.006,-0.006999999999999999
572,573,20,13,LFIB4: Lipoaffinity index distribution of 1.00B,Solubility lipoaffinity,#D1963A,1.000052,0.999933,1.000056,1.000033
573,574,20,14,SLFB4: Sum of path lengths starting from oxygens_3 distribution of 1.00B,Topological indice,#B4B044,1.000052,0.999933,1.000056,1.000033
574,575,20,15,AABA2: Dinucleotide auto covariance of lag2 on ABA,Nucleotide related,#ED7D31,0.006999999999999999,0.001,-0.006999999999999999,0.005
575,576,20,16,HPCB4: Gas-hexadecane PC_3 distribution of 1.00B,Partition coefficient,#C6CEBA,0.99948,1.000033,1.0,1.0
576,577,20,17,CNHB4: NH- count distribution of 1.00B,Molecular fingerprint,#9AB6D1,0.999844,0.999867,0.999944,0.999933
577,578,20,18,CC205: Cross covariance of lag2 on PID-SLI,Nucleotide related,#ED7D31,-0.019,-0.014,-0.042,-0.016
578,579,20,19,ATWI1: Dinucleotide auto covariance of lag1 on TWI,Nucleotide related,#ED7D31,-0.343,-0.325,-0.363,-0.343
579,580,20,20,CC120: Cross covariance of lag1 on SKE-SLI,Nucleotide related,#ED7D31,-0.233,-0.209,-0.258,-0.213
580,581,20,21,TraES: Entropy density S on transcript,Transcript related,#CCB441,0.078102,0.078126,0.07710700000000001,0.08244299999999999
581,582,20,22,SHD: Strong H-Bond donors100,Hydrogen bond related,#FFC000,118.83606,130.204346,119.692413,130.037674
582,583,20,23,LFI: Lipoaffinity index_3012,Solubility lipoaffinity,#D1963A,29.462198,42.601421,28.530035,42.234741
583,584,20,24,ORFEQ: Entropy density Q on ORF,Open reading frame,#BDC6CF,0.022391,0.036692,0.02325,0.0448
584,585,20,25,CNH: NH- count100,Molecular fingerprint,#9AB6D1,124.084175,124.704155,126.379135,123.170769
585,586,20,26,TraEQ: Entropy density Q on transcript,Transcript related,#CCB441,0.041183,0.051342,0.041341,0.047669
586,588,21,0,CC123: Cross covariance of lag1 on WCI-ETI,Nucleotide related,#ED7D31,0.443,0.418,0.416,0.397
587,589,21,1,ADST1: Dinucleotide auto covariance of lag1 on DST,Nucleotide related,#ED7D31,0.3,0.301,0.29100000000000004,0.279
588,590,21,2,ASDG1: Dinucleotide auto covariance of lag1 on SDG,Nucleotide related,#ED7D31,0.279,0.25,0.274,0.243
589,591,21,3,AETI2: Dinucleotide auto covariance of lag2 on ETI,Nucleotide related,#ED7D31,0.035,0.023,-0.006,-0.01
590,592,21,4,CC117: Cross covariance of lag1 on SKE-BDS,Nucleotide related,#ED7D31,0.278,0.238,0.277,0.234
591,593,21,5,CC214: Cross covariance of lag2 on ETI-WCI,Nucleotide related,#ED7D31,0.035,0.023,-0.006,-0.01
592,594,21,6,CC207: Cross covariance of lag2 on BDS-ETI,Nucleotide related,#ED7D31,0.031,0.009000000000000001,-0.006,-0.016
593,595,21,7,CC209: Cross covariance of lag2 on BDS-WCI,Nucleotide related,#ED7D31,0.031,0.009000000000000001,-0.006,-0.016
594,596,21,8,ABDS2: Dinucleotide auto covariance of lag2 on BDS,Nucleotide related,#ED7D31,0.033,-0.003,-0.0,-0.021
595,597,21,9,AROL2: Dinucleotide auto covariance of lag2 on ROL,Nucleotide related,#ED7D31,0.029,0.028,-0.011,0.02
596,598,21,10,CC111: Cross covariance of lag1 on ETI-PID,Nucleotide related,#ED7D31,0.129,0.141,0.127,0.132
597,599,21,11,AIBA1: Dinucleotide auto covariance of lag1 on IBA,Nucleotide related,#ED7D31,-0.075,-0.122,-0.099,-0.127
598,600,21,12,L1PID: Series correlation PseDN composition of lamda1-PID,Nucleotide related,#ED7D31,-0.0078,-0.0089,-0.0085,-0.0087
599,601,21,13,ABDT1: Dinucleotide auto covariance of lag1 on BDT,Nucleotide related,#ED7D31,-0.066,-0.107,-0.071,-0.101
600,602,21,14,LFIB4: Lipoaffinity index_3 distribution of 1.00B,Solubility lipoaffinity,#D1963A,1.000052,0.999933,1.000056,1.000033
601,603,21,15,DPRT4: Distribution of 1.00T,Transcript related,#CCB441,0.99974,0.9998,0.999889,0.999767
602,604,21,16,ASDS2: Dinucleotide auto covariance of lag2 on SDS,Nucleotide related,#ED7D31,-0.006999999999999999,-0.015,-0.012,-0.012
603,605,21,17,ASDH2: Dinucleotide auto covariance of lag2 on SDH,Nucleotide related,#ED7D31,-0.022,-0.04,-0.027000000000000003,-0.032
604,606,21,18,ORFES: Entropy density S on ORF,Open reading frame,#BDC6CF,0.073394,0.072018,0.10924,0.119539
605,607,21,19,CC216: Cross covariance of lag2 on SKE-PID,Nucleotide related,#ED7D31,0.012,0.014,-0.002,0.003
606,608,21,20,ARIS1: Dinucleotide auto covariance of lag1 on RIS,Nucleotide related,#ED7D31,-0.34700000000000003,-0.311,-0.384,-0.331
607,609,21,21,LFI: Lipoaffinity index010,Solubility lipoaffinity,#D1963A,131.410751,139.47131299999998,135.239044,143.271439
608,610,21,22,SHD: Strong H-Bond donors001,Hydrogen bond related,#FFC000,118.784103,130.171005,119.636688,130.004333
609,611,21,23,SHD: Strong H-Bond donors010,Hydrogen bond related,#FFC000,114.419327,117.837265,122.255653,124.370811
610,612,21,24,SLF: Sum of path lengths starting from oxygens_301,Topological indice,#B4B044,118.316444,141.504715,118.80085,137.037903
611,613,21,25,SLFAB: Sum of path lengths starting from oxygens_3 transition between A and B,Topological indice,#B4B044,0.227251,0.274061,0.22960300000000006,0.270594
612,614,21,26,SLF: Sum of path lengths starting from oxygens_310,Topological indice,#B4B044,108.911407,132.53775,110.776772,133.537781
613,616,22,0,CC122: Cross covariance of lag1 on WCI-BDS,Nucleotide related,#ED7D31,0.422,0.411,0.392,0.381
614,617,22,1,ASDG2: Dinucleotide auto covariance of lag2 on SDG,Nucleotide related,#ED7D31,0.005,-0.02,-0.025,-0.035
615,618,22,2,ABDG2: Dinucleotide auto covariance of lag2 on BDG,Nucleotide related,#ED7D31,0.012,-0.015,0.005,-0.014
616,619,22,3,AHCT2: Dinucleotide auto covariance of lag2 on HCT,Nucleotide related,#ED7D31,0.012,-0.015,0.004,-0.014
617,620,22,4,ADGC2: Dinucleotide auto covariance of lag2 on DGC,Nucleotide related,#ED7D31,0.035,0.023,-0.006,-0.01
618,621,22,5,CC223: Cross covariance of lag2 on WCI-ETI,Nucleotide related,#ED7D31,0.035,0.023,-0.006,-0.01
619,622,22,6,CC204: Cross covariance of lag2 on PID-WCI,Nucleotide related,#ED7D31,0.019,0.035,0.01,0.017
620,623,22,7,CC212: Cross covariance of lag2 on ETI-BDS,Nucleotide related,#ED7D31,0.035,0.01,0.003,-0.018000000000000002
621,624,22,8,CC222: Cross covariance of lag2 on WCI-BDS,Nucleotide related,#ED7D31,0.035,0.01,0.003,-0.018000000000000002
622,625,22,9,ABDH2: Dinucleotide auto covariance of lag2 on BDH,Nucleotide related,#ED7D31,0.006999999999999999,-0.022,0.014,-0.009000000000000001
623,626,22,10,CC106: Cross covariance of lag1 on BDS-PID,Nucleotide related,#ED7D31,0.117,0.123,0.118,0.115
624,627,22,11,ADDT1: Dinucleotide auto covariance of lag1 on DDT,Nucleotide related,#ED7D31,0.03,0.023,0.011,0.016
625,628,22,12,AAPH1: Dinucleotide auto covariance of lag1 on APH,Nucleotide related,#ED7D31,-0.075,-0.122,-0.099,-0.127
626,629,22,13,SHDA3: Strong H-Bond donors distribution of 0.75A,Hydrogen bond related,#FFC000,0.7516109999999999,0.754684,0.7470600000000001,0.753517
627,630,22,14,APID1: Dinucleotide auto covariance of lag1 on PID,Nucleotide related,#ED7D31,-0.185,-0.192,-0.196,-0.193
628,631,22,15,DPRA4: Distribution of 1.00A,Transcript related,#CCB441,0.999948,0.9999,0.999833,0.999933
629,632,22,16,SHAA3: Strong H-Bond acceptors_3 distribution of 0.75A,Hydrogen bond related,#FFC000,0.745739,0.746616,0.742101,0.740683
630,633,22,17,DPRC4: Distribution of 1.00C,Transcript related,#CCB441,0.999428,0.999967,0.999944,0.999967
631,634,22,18,CC203: Cross covariance of lag2 on PID-SKE,Nucleotide related,#ED7D31,-0.005,0.027000000000000003,-0.022,0.014
632,635,22,19,ASEZ1: Dinucleotide auto covariance of lag1 on SEZ,Nucleotide related,#ED7D31,-0.241,-0.21,-0.268,-0.23
633,636,22,20,AHTF1: Dinucleotide auto covariance of lag1 on HTF,Nucleotide related,#ED7D31,-0.221,-0.196,-0.255,-0.214
634,637,22,21,LFI: Lipoaffinity index100,Solubility lipoaffinity,#D1963A,132.346069,133.837799,134.458939,133.97113000000002
635,638,22,22,PHB: Potential Hydrogen Bonds_302,Hydrogen bond related,#FFC000,141.12756299999995,163.53878799999995,144.210403,161.538712
636,639,22,23,PHBAC: Potential Hydrogen Bonds_3 transition between A and C,Hydrogen bond related,#FFC000,0.247882,0.278795,0.252842,0.281862
637,640,22,24,LFI: Lipoaffinity index_3120,Solubility lipoaffinity,#D1963A,27.227852,35.234509,30.368885,36.934563
638,641,22,25,SCDAC: Series correlation PseDN composition of AC,Nucleotide related,#ED7D31,0.057,0.081,0.057,0.08199999999999999
639,642,22,26,PCDAC: Parallel correlation PseDN composition of AC,Nucleotide related,#ED7D31,0.052000000000000005,0.07200000000000001,0.052000000000000005,0.073
640,644,23,0,CC112: Cross covariance of lag1 on ETI-BDS,Nucleotide related,#ED7D31,0.422,0.411,0.392,0.381
641,645,23,1,CC219: Cross covariance of lag2 on SKE-WCI,Nucleotide related,#ED7D31,0.014,-0.018000000000000002,-0.016,-0.035
642,646,23,2,ADST2: Dinucleotide auto covariance of lag2 on DST,Nucleotide related,#ED7D31,0.026,0.013,0.002,-0.006
643,647,23,3,ASMS2: Dinucleotide auto covariance of lag2 on SMS,Nucleotide related,#ED7D31,-0.027000000000000003,-0.079,-0.045,-0.07200000000000001
644,648,23,4,AWCI2: Dinucleotide auto covariance of lag2 on WCI,Nucleotide related,#ED7D31,0.035,0.023,-0.006,-0.01
645,649,23,5,APTW2: Dinucleotide auto covariance of lag2 on PTW,Nucleotide related,#ED7D31,0.045,0.046,0.014,0.016
646,650,23,6,CC202: Cross covariance of lag2 on PID-ETI,Nucleotide related,#ED7D31,0.019,0.035,0.01,0.017
647,651,23,7,CC221: Cross covariance of lag2 on WCI-PID,Nucleotide related,#ED7D31,0.024,0.029,0.015,0.021
648,652,23,8,CC201: Cross covariance of lag2 on PID-BDS,Nucleotide related,#ED7D31,0.019,0.028,0.008,0.011
649,653,23,9,MLFA3: Linear free energy distribution of 0.75A,Hydrogen bond related,#FFC000,0.774839,0.74795,0.75854,0.747316
650,654,23,10,SHDA1: Strong H-Bond donors distribution of 0.25A,Hydrogen bond related,#FFC000,0.252858,0.25205,0.252494,0.252283
651,655,23,11,ORFIn: ORF integrity,Open reading frame,#BDC6CF,1.0,1.0,1.0,1.0
652,656,23,12,DPRT3: Distribution of 0.75T,Transcript related,#CCB441,0.747311,0.754858,0.727739,0.742458
653,657,23,13,HPCC3: Gas-hexadecane PC_3 distriCution of 0.75C,Partition coefficient,#C6CEBA,0.74735,0.754884,0.727779,0.742483
654,658,23,14,LFIA3: Lipoaffinity index_3 distribution of 0.75A,Solubility lipoaffinity,#D1963A,0.717938,0.7623840000000001,0.720312,0.75245
655,659,23,15,LFIA3: Lipoaffinity index distribution of 0.75A,Solubility lipoaffinity,#D1963A,0.725421,0.75365,0.73168,0.74865
656,660,23,16,CNHB3: NH- count distribution of 0.75B,Molecular fingerprint,#9AB6D1,0.745739,0.746616,0.742101,0.740683
657,661,23,17,CNHB2: NH- count distribution of 0.50B,Molecular fingerprint,#9AB6D1,0.49948,0.491366,0.506158,0.488699
658,662,23,18,SHAA2: Strong H-Bond acceptors_3 distribution of 0.50A,Hydrogen bond related,#FFC000,0.49948,0.491366,0.506158,0.488699
659,663,23,19,PPMFS: Pseudo protein PI-MW frame score,Pseudo protein related,#B3CE93,3.211754,3.3333730000000004,3.468522,3.386508
660,664,23,20,ALBZ1: Dinucleotide auto covariance of lag1 on LBZ,Nucleotide related,#ED7D31,-0.221,-0.195,-0.255,-0.213
661,665,23,21,LFI: Lipoaffinity index001,Solubility lipoaffinity,#D1963A,132.398026,133.804459,134.514648,133.97113000000002
662,666,23,22,TraED: Entropy density D on transcript,Transcript related,#CCB441,0.028487,0.030327,0.031249,0.028396
663,667,23,23,PHB: Potential Hydrogen Bonds_320,Hydrogen bond related,#FFC000,106.729019,115.237175,108.603592,120.304008
664,668,23,24,LFI: Lipoaffinity index_3021,Solubility lipoaffinity,#D1963A,19.901274,20.567352,20.561686,20.367346
665,669,23,25,SCDCA: Series correlation PseDN composition of CA,Nucleotide related,#ED7D31,0.049,0.062,0.049,0.062
666,670,23,26,TraAG: Transition between A and G,Transcript related,#CCB441,0.112607,0.14841,0.111507,0.148977
667,672,24,0,ABDS1: Dinucleotide auto covariance of lag1 on BDS,Nucleotide related,#ED7D31,0.401,0.403,0.366,0.364
668,673,24,1,ASMG2: Dinucleotide auto covariance of lag2 on SMG,Nucleotide related,#ED7D31,0.025,0.018000000000000002,0.001,-0.002
669,674,24,2,ADTB2: Dinucleotide auto covariance of lag2 on DTB,Nucleotide related,#ED7D31,0.006,-0.016,0.001,-0.016
670,675,24,3,ASMH2: Dinucleotide auto covariance of lag2 on SMH,Nucleotide related,#ED7D31,-0.014,-0.059,-0.035,-0.059
671,676,24,4,APIA2: Dinucleotide auto covariance of lag2 on PIA,Nucleotide related,#ED7D31,0.035,0.023,-0.006,-0.01
672,677,24,5,CC211: Cross covariance of lag2 on ETI-PID,Nucleotide related,#ED7D31,0.024,0.029,0.015,0.021
673,678,24,6,CC206: Cross covariance of lag2 on BDS-PID,Nucleotide related,#ED7D31,0.022,0.024,0.014,0.017
674,679,24,7,SHAB3: Strong H-Bond acceptors_3 distribution of 0.75B,Hydrogen bond related,#FFC000,0.797651,0.741916,0.784452,0.7552840000000001
675,680,24,8,HPCA3: Gas-hexadecane PC distribution of 0.75A,Partition coefficient,#C6CEBA,0.76746,0.744316,0.760045,0.74505
676,681,24,9,HPCA2: Gas-hexadecane PC distribution of 0.50A,Partition coefficient,#C6CEBA,0.521305,0.505634,0.509446,0.500967
677,682,24,10,PHBA2: Potential Hydrogen Bonds_3 distribution of 0.50A,Hydrogen bond related,#FFC000,0.5278010000000001,0.528669,0.508108,0.512668
678,683,24,11,PHBA3: Potential Hydrogen Bonds_3 distribution of 0.75A,Hydrogen bond related,#FFC000,0.774839,0.74795,0.75854,0.747316
679,684,24,12,SHDA2: Strong H-Bond donors distribution of 0.50A,Hydrogen bond related,#FFC000,0.500104,0.512634,0.497353,0.5078010000000001
680,685,24,13,SLFC3: Sum of path lengths starting from oxygens_3 distriCution of 0.75C,Topological indice,#B4B044,0.74735,0.754884,0.727779,0.742483
681,686,24,14,TPSB3: Topological polar surface area_3 distribution of 0.75B,Topological indice,#B4B044,0.74735,0.754884,0.727779,0.742483
682,687,24,15,MReB3: Molar refractivity distribution of 0.75B,Polarizability refractivity,#A0CF6D,0.717938,0.7623840000000001,0.720312,0.75245
683,688,24,16,MReB1: Molar refractivity distribution of 0.25B,Polarizability refractivity,#A0CF6D,0.237892,0.254484,0.241906,0.24675
684,689,24,17,LFIA2: Lipoaffinity index_3 distribution of 0.50A,Solubility lipoaffinity,#D1963A,0.473134,0.503,0.486096,0.498
685,690,24,18,SHAA1: Strong H-Bond acceptors_3 distribution of 0.25A,Hydrogen bond related,#FFC000,0.24101,0.244516,0.250989,0.239783
686,691,24,19,TPSA3: Topological polar surface area_3 distribution of 0.75A,Topological indice,#B4B044,0.754729,0.754384,0.7569239999999999,0.759851
687,692,24,20,TPSA1: Topological polar surface area_3 distribution of 0.25A,Topological indice,#B4B044,0.259146,0.25608400000000003,0.248983,0.261751
688,693,24,21,ORFED: Entropy density D on ORF,Open reading frame,#BDC6CF,0.030358,0.02976,0.0,0.029861
689,694,24,22,MRe: Molar refractivity100,Polarizability refractivity,#A0CF6D,106.780983,120.737358,104.312943,117.40391499999998
690,695,24,23,LFI: Lipoaffinity index_3210,Solubility lipoaffinity,#D1963A,24.941544,23.734125,21.620417,23.100771
691,696,24,24,MRe: Molar refractivity0,Polarizability refractivity,#A0CF6D,463.91272,514.283813,463.334442,506.383545
692,697,24,25,PCDCA: Parallel correlation PseDN composition of CA,Nucleotide related,#ED7D31,0.045,0.055,0.044,0.055
693,698,24,26,LFIBC: Lipoaffinity index_3 transition between B and C,Solubility lipoaffinity,#D1963A,0.112612,0.14841500000000002,0.11151400000000003,0.148982
694,700,25,0,CC218: Cross covariance of lag2 on SKE-ETI,Nucleotide related,#ED7D31,0.014,-0.018000000000000002,-0.016,-0.035
695,701,25,1,CC217: Cross covariance of lag2 on SKE-BDS,Nucleotide related,#ED7D31,0.015,-0.024,-0.006,-0.04
696,702,25,2,MReA3: Molar refractivity distribution of 0.75A,Polarizability refractivity,#A0CF6D,0.778217,0.738116,0.777375,0.74735
697,703,25,3,HPCA3: Gas-hexadecane PC_3 distribution of 0.75A,Partition coefficient,#C6CEBA,0.778217,0.738116,0.777375,0.74735
698,704,25,4,LFIB3: Lipoaffinity index distribution of 0.75B,Solubility lipoaffinity,#D1963A,0.797651,0.741916,0.784452,0.7552840000000001
699,705,25,5,SLFB3: Sum of path lengths starting from oxygens_3 distribution of 0.75B,Topological indice,#B4B044,0.797651,0.741916,0.784452,0.7552840000000001
700,706,25,6,LFIB3: Lipoaffinity index_3 distribution of 0.75B,Solubility lipoaffinity,#D1963A,0.797651,0.741916,0.784452,0.7552840000000001
701,707,25,7,SHAB2: Strong H-Bond acceptors_3 distribution of 0.50B,Hydrogen bond related,#FFC000,0.5619930000000001,0.530802,0.519309,0.522335
702,708,25,8,DPRA2: Distribution of 0.50A,Transcript related,#CCB441,0.5616,0.530784,0.518779,0.522317
703,709,25,9,HPCA1: Gas-hexadecane PC distribution of 0.25A,Partition coefficient,#C6CEBA,0.256392,0.245916,0.259682,0.24755
704,710,25,10,MLFA2: Linear free energy distribution of 0.50A,Hydrogen bond related,#FFC000,0.5278010000000001,0.528669,0.508108,0.512668
705,711,25,11,PHBA1: Potential Hydrogen Bonds_3 distribution of 0.25A,Hydrogen bond related,#FFC000,0.261484,0.24605,0.266147,0.249017
706,712,25,12,MLFA1: Linear free energy distribution of 0.25A,Hydrogen bond related,#FFC000,0.261484,0.24605,0.266147,0.249017
707,713,25,13,PSNB1: Primary or secondary nitrogens distribution of 0.25B,Topological indice,#B4B044,0.242985,0.241316,0.259181,0.235682
708,714,25,14,PSNB2: Primary or secondary nitrogens distribution of 0.50B,Topological indice,#B4B044,0.499013,0.5262020000000001,0.501644,0.498633
709,715,25,15,SLFC2: Sum of path lengths starting from oxygens_3 distriCution of 0.50C,Topological indice,#B4B044,0.499013,0.5262020000000001,0.501644,0.498633
710,716,25,16,PSNB3: Primary or secondary nitrogens distribution of 0.75B,Topological indice,#B4B044,0.74735,0.754884,0.727779,0.742483
711,717,25,17,LFIA1: Lipoaffinity index_3 distribution of 0.25A,Solubility lipoaffinity,#D1963A,0.237892,0.254484,0.241906,0.24675
712,718,25,18,MReB2: Molar refractivity distribution of 0.50B,Polarizability refractivity,#A0CF6D,0.473134,0.503,0.486096,0.498
713,719,25,19,CNHB1: NH- count distribution of 0.25B,Molecular fingerprint,#9AB6D1,0.24101,0.244516,0.250989,0.239783
714,720,25,20,TPSA2: Topological polar surface area_3 distribution of 0.50A,Topological indice,#B4B044,0.500468,0.507667,0.4944,0.512234
715,721,25,21,CNHA1: NH- count distribution of 0.25A,Molecular fingerprint,#9AB6D1,0.259146,0.25608400000000003,0.248983,0.261751
716,722,25,22,MRe: Molar refractivity001,Polarizability refractivity,#A0CF6D,106.729019,120.770691,104.36866,117.437248
717,723,25,23,MReCA: Molar refractivity composition of A,Polarizability refractivity,#A0CF6D,0.463937,0.514301,0.4633600000000001,0.5064
718,724,25,24,MRe: Molar refractivity00,Polarizability refractivity,#A0CF6D,241.361389,302.44342,232.140869,290.54303
719,725,25,25,TraEE: Entropy density E on transcript,Transcript related,#CCB441,0.035293,0.048656,0.038739,0.047514
720,726,25,26,ORFEE: Entropy density E on ORF,Open reading frame,#BDC6CF,0.013034,0.067945,0.0,0.024038
721,728,26,0,HPCA2: Gas-hexadecane PC_3 distribution of 0.50A,Partition coefficient,#C6CEBA,0.537622,0.497733,0.515185,0.502033
722,729,26,1,MReA2: Molar refractivity distribution of 0.50A,Polarizability refractivity,#A0CF6D,0.537622,0.497733,0.515185,0.502033
723,730,26,2,HPCA1: Gas-hexadecane PC_3 distribution of 0.25A,Partition coefficient,#C6CEBA,0.266473,0.24725,0.260017,0.25305
724,731,26,3,MReA1: Molar refractivity distribution of 0.25A,Polarizability refractivity,#A0CF6D,0.266473,0.24725,0.260017,0.25305
725,732,26,4,DPRA3: Distribution of 0.75A,Transcript related,#CCB441,0.797558,0.741891,0.784297,0.755192
726,733,26,5,LFIB2: Lipoaffinity index_3 distribution of 0.50B,Solubility lipoaffinity,#D1963A,0.5619930000000001,0.530802,0.519309,0.522335
727,734,26,6,SLFB2: Sum of path lengths starting from oxygens_3 distribution of 0.50B,Topological indice,#B4B044,0.5619930000000001,0.530802,0.519309,0.522335
728,735,26,7,LFIB2: Lipoaffinity index distribution of 0.50B,Solubility lipoaffinity,#D1963A,0.5619930000000001,0.530802,0.519309,0.522335
729,736,26,8,SLFB1: Sum of path lengths starting from oxygens_3 distribution of 0.25B,Topological indice,#B4B044,0.283465,0.249483,0.271663,0.263718
730,737,26,9,LFIB1: Lipoaffinity index_3 distribution of 0.25B,Solubility lipoaffinity,#D1963A,0.283465,0.249483,0.271663,0.263718
731,738,26,10,LFIB1: Lipoaffinity index distribution of 0.25B,Solubility lipoaffinity,#D1963A,0.283465,0.249483,0.271663,0.263718
732,739,26,11,DPRA1: Distribution of 0.25A,Transcript related,#CCB441,0.28345,0.249475,0.271648,0.263709
733,740,26,12,SHAB1: Strong H-Bond acceptors_3 distribution of 0.25B,Hydrogen bond related,#FFC000,0.283465,0.249483,0.271663,0.263718
734,741,26,13,DPRT1: Distribution of 0.25T,Transcript related,#CCB441,0.242972,0.241308,0.259166,0.235675
735,742,26,14,TPSB1: Topological polar surface area_3 distribution of 0.25B,Topological indice,#B4B044,0.242985,0.241316,0.259181,0.235682
736,743,26,15,HPCC1: Gas-hexadecane PC_3 distriCution of 0.25C,Partition coefficient,#C6CEBA,0.242985,0.241316,0.259181,0.235682
737,744,26,16,SLFC1: Sum of path lengths starting from oxygens_3 distriCution of 0.25C,Topological indice,#B4B044,0.242985,0.241316,0.259181,0.235682
738,745,26,17,TPSB2: Topological polar surface area_3 distribution of 0.50B,Topological indice,#B4B044,0.499013,0.5262020000000001,0.501644,0.498633
739,746,26,18,HPCC2: Gas-hexadecane PC_3 distriCution of 0.50C,Partition coefficient,#C6CEBA,0.499013,0.5262020000000001,0.501644,0.498633
740,747,26,19,DPRT2: Distribution of 0.50T,Transcript related,#CCB441,0.498987,0.526184,0.501616,0.498617
741,748,26,20,CNHA3: NH- count distribution of 0.75A,Molecular fingerprint,#9AB6D1,0.754729,0.754384,0.7569239999999999,0.759851
742,749,26,21,CNHA2: NH- count distribution of 0.50A,Molecular fingerprint,#9AB6D1,0.500468,0.507667,0.4944,0.512234
743,750,26,22,HPC: Gas-hexadecane PC_30,Partition coefficient,#C6CEBA,463.91272,514.283813,463.334442,506.383545
744,751,26,23,HPCCA: Gas-hexadecane PC_3 composition of A,Partition coefficient,#C6CEBA,0.463937,0.514301,0.4633600000000001,0.5064
745,752,26,24,HPC: Gas-hexadecane PC_300,Partition coefficient,#C6CEBA,241.361389,302.44342,232.140869,290.54303
746,753,26,25,HPC: Gas-hexadecane PC_3000,Partition coefficient,#C6CEBA,134.580414,181.672729,127.772209,173.105774
747,754,26,26,MRe: Molar refractivity000,Polarizability refractivity,#A0CF6D,134.580414,181.672729,127.772209,173.105774
